https://www.dailyhealthindustry.it/investimenti-diretti-esteri-calano-anche-nel-pharma/ 2022-06-10T13:17:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-ema-adotta-elenco-farmaci-per-lemergenza-sanitaria/ 2022-06-10T13:23:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-nuovi-dati-positivi-per-teclistamab-nel-mieloma-multiplo-recidivato-o-refrattario/ 2022-06-10T14:19:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viatris-con-cergas-bocconi-progetto-di-analisi-dei-servizi-sanitari-territoriali-in-quattro-regioni-alla-luce-del-pnrr/ 2022-06-13T09:19:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-covid-19-vaccino-pfizer-biontech-efficace-e-sicura-nei-bambini-6-mesi-4-anni/ 2022-06-13T09:48:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-punta-al-trattamento-dellobesita-con-lantidiabetico-tirzepatide/ 2022-06-13T15:51:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-gsk-forte-risposta-immunitaria-del-nuovo-vaccino-covid-contro-varianti-omicron/ 2022-06-13T13:50:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/al-via-il-xxii-convegno-aiic-un-premio-americano-per-confermare-una-presenza-professionale-essenziale-nel-panorama-della-sanita/ 2022-06-13T13:15:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-oncoematologiche-e-ora-di-riconoscerle-tra-le-cronicita/ 2022-06-13T14:40:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/xxii-convegno-aiic-2-allarme-cybersecurity-proteggere-i-sistemi-grazie-a-formazione-e-governance/ 2022-06-14T09:07:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmindustria-rinnovato-ccnl-dei-settori-chimico-e-farmaceutico/ 2022-06-14T09:22:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-rafforza-la-pipeline-antiinfettiva-acquisita-reviral/ 2022-06-14T09:49:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-dati-positivi-a-5-anni-per-kymriah-nella-lla/ 2022-06-14T13:00:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/xxii-convegno-aiic-3-per-una-telemedicina-efficiente-non-bastano-le-tecnologie-servono-competenze-e-risorse-umane/ 2022-06-14T13:20:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-rallentano-le-ipo/ 2022-06-14T13:41:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/xxii-convegno-aiic4-health-technology-assessment-a-un-punto-di-svolta/ 2022-06-15T12:32:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/icar-2022-una-persona-su-due-con-hiv-non-parla-della-propria-positivita-lindagine-fondazione-icona/ 2022-06-15T10:34:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-vaccino-contro-la-dengue-protegge-per-oltre-quattro-anni/ 2022-06-15T10:36:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bluebird-bio-ok-panel-di-esperti-fda-a-due-terapie-geniche-contro-malattie-rare/ 2022-06-15T12:30:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/concluso-il-xxii-convegno-aiic-nocco-tecnologie-utili-sono-quelle-che-rispondono-a-chiari-bisogni-clinici/ 2022-06-15T14:50:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-aifa-autorizza-livelli-di-ldl-piu-bassi-per-la-prescrivibilita-di-alirocumab-in-pazienti-ad-alto-rischio-cardiovascolare/ 2022-06-16T09:34:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dr-reddys-accordo-con-olema-pharmaceuticals-per-inibitori-small-molecules/ 2022-06-17T15:02:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-aumentano-le-aziende-che-assumono-in-ambito-iot/ 2022-06-16T12:58:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-via-alla-rolling-review-vaccino-covid-19-pfizerbiontech-adattato-alle-nuove-varianti/ 2022-06-16T13:32:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-e-nordic-bioscience-collaborazione-per-sviluppo-biomarcatori-malattie-croniche/ 2022-06-17T09:15:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-e-bachem-accordo-per-i-prodotti-oligonucleotidici/ 2022-06-17T09:15:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/the-lancet-vaccino-covid-19-astrazeneca-ben-tollerato-ed-efficace-nella-fascia-617-anni/ 2022-06-17T12:14:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cannes-lions-health-per-ladv-pharma-e-il-momento-del-gioco-integrato/ 2022-06-17T12:24:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-pfizer-l81-di-valneva/ 2022-06-20T09:58:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-italia-ed-allergan-aesthetics-dipendenti-volontari-nella-week-of-possibilities-per-supportare-le-comunita-locali/ 2022-06-20T10:24:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-covid19-partita-anche-la-rolling-review-del-vaccino-di-moderna/ 2022-06-20T10:48:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-opzione-di-acquisto-su-biotech-usa/ 2022-06-20T15:20:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-lancia-il-digital-accelerator/ 2022-06-20T13:08:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanitalk-6-pnrr-servono-personale-e-formazione-molto-diversa-da-come-labbiamo-fatta-fino-ad-oggi/ 2022-06-20T15:56:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ggg/ 2022-06-20T15:02:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-aifa-rinnova-il-riconoscimento-di-innovativita-piena-a-zolgensma-sma/ 2022-06-21T09:23:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/health-serie-oncologia-di-precisione-verso-la-medicina-del-futuro/ 2022-06-22T12:18:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-orfani-e-arrivato-il-momento-della-svolta/ 2022-06-21T10:43:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lions-health-i-vincitori-delledizione-2022/ 2022-06-21T12:33:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-le-aziende-assumono-nel-machine-learning/ 2022-06-22T13:31:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-a-milano-con-il-cane-in-ufficio-per-vivere-meglio-le-ore-di-lavoro/ 2022-06-22T13:52:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/morena-sangiovanni-nel-cda-di-ahk-italien-la-camera-di-commercio-italo-tedesca/ 2022-06-22T14:12:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-sfida-il-tumore-del-polmone-con-il-progetto-breathink/ 2022-06-22T14:48:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/parkinson-non-e-una-malattia-degli-anziani-piu-attenzione-a-giovani-pazienti-e-alle-famiglie-ma-la-legge-sui-caregiver-e-a-rischio/ 2022-06-23T09:29:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-covid-19-nuovo-vaccino-booster-efficace-anche-nei-sottogruppi-di-omicron/ 2022-06-23T14:36:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ue-rilancia-gli-investimenti-per-produzione-farmaci-e-vaccini-in-america-latina/ 2022-06-23T10:12:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lorenzo-wittum-astrazeneca-nuovo-chairman-aziende-europee-e-giapponesi-di-farmindustria/ 2022-06-23T10:24:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-1-mld-di-sterline-in-rs-in-10-anni-per-combattere-le-malattie-infettive-nei-paesi-a-basso-reddito/ 2022-06-23T12:43:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-e-ionis-buoni-risultati-per-farmaco-contro-patologia-rara-e-fatale/ 2022-06-23T13:40:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/digital-medicine-il-futuro-delle-cure-passa-anche-da-qui/ 2022-06-23T14:29:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cart-galapagos-acquisisce-cellpoint-e-aboundbio-obiettivo-accelerare-laccesso-alle-terapie-cellulari-di-nuova-generazione/ 2022-06-24T07:41:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/valneva-ok-ema-a-vaccino-covid-ma-rimane-nodo-forniture/ 2022-06-24T09:43:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-torna-in-confindustria-dispositivi-medici/ 2022-06-24T13:02:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/metaverso-e-internet-of-place-per-i-manager-e-il-futuro/ 2022-06-24T13:46:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rimborsabilita-di-pemigatinib-per-il-colangiocarcinoma-in-italia/ 2022-06-24T15:03:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-italia-sponsor-del-milano-pride-2022/ 2022-06-27T10:15:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biomarin-ok-ema-ad-approvazione-condizionata-di-roctavian-emofilia/ 2022-06-27T10:48:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-biontech-i-nuovi-vaccini-anti-covid-migliorano-la-risposta-a-omicron/ 2022-06-27T15:10:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-dai-congressi-asco-ed-eha-nuovi-dati-su-ibrutinib-in-terapia-di-combinazione/ 2022-06-27T15:18:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/congresso-sidemast-giuseppe-monfrecola-e-il-nuovo-presidente/ 2022-06-27T15:51:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lundbeck-e-otsuka-farmaco-per-la-depressione-efficace-nel-ridurre-lagitazione-nella-malattia-di-alzheimer/ 2022-06-28T15:44:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-un-cortometraggio-per-superare-le-paure-della-psoriasi/ 2022-06-28T11:06:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-ucb-pharma-italia-il-premio-leads-nella-categoria-impresa/ 2022-06-28T13:28:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipsen-acquisisce-la-biotech-epizyme/ 2022-06-28T14:15:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-home-delivery-cgm-acquisisce-il-60-di-pharmap/ 2022-06-28T15:08:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaceutica-italia-prima-in-ue-per-produzione-ma-ancora-indietro-per-ricerca-il-647-del-totale-delle-vendite-e-da-generici/ 2022-06-30T09:37:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/25311/ 2022-06-30T10:00:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-il-congresso-valuta-un-limite-al-costo-dellinsulina-e-sanofi-riduce-il-prezzo-per-i-non-assicurati/ 2022-06-30T10:19:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-johnson-rinnova-la-campagna-hiv-positively-fearless-con-una-nuova-presenza-digitale-e-un-ambasciatore-lgbtq/ 2022-06-30T12:09:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tpg-investe-nel-principale-produttore-di-farmaci-generici-doc-generici/ 2022-06-30T12:17:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/telemedicina-una-possibilita-per-assistere-i-pazienti-in-fuga-dallucraina-al-via-progetto-di-takeda-spallanzani-regione-lazio-e-adilife/ 2022-06-30T14:26:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/veeva-la-trasformazione-delle-lifescience-in-italia-e-in-europa/ 2022-07-01T06:50:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lautunno-caldo-della-fda/ 2022-07-01T13:18:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-innovativi-il-mercato-e-vivo-ma-le-performance-non-sono-buone/ 2022-07-01T13:58:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-ok-della-ce-a-due-terapie-enzimatiche-sostitutive-per-malattie-rare/ 2022-07-01T14:10:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/da-pfizer-e-roivant-nasce-priovant-therapeutics-specializzata-in-farmaci-antinfiammatori/ 2022-07-04T11:43:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-accordo-con-sutro-biopharma-per-antitumorali-coniugati-farmaco-anticorpo/ 2022-07-04T11:42:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-michal-nitka-gm-italia-e-sud-est-europa-umberto-comberiati-ad-italia/ 2022-07-04T15:32:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lilly-via-libera-ema-a-baricitinib-nellalopecia-areata/ 2022-07-04T13:18:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dedalus-acquisisce-divisione-healthcare-software-del-gruppo-lutech/ 2022-07-05T10:16:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-diagnostics-burcak-celik-e-la-nuova-general-manager/ 2022-07-05T09:49:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccini-covid19-astrazeneca-e-oxford-biomedica-estendono-accordo-di-produzione/ 2022-07-05T10:25:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-presentato-il-nuovo-laboratorio-di-controllo-qualita-nello-stabilimento-di-pisa/ 2022-07-05T15:58:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/zambon-ilaria-villa-nominata-direttore-generale/ 2022-07-05T13:45:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novavax-ok-ce-a-vaccino-covid-negli-adolescenti-1217anni/ 2022-07-05T14:08:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbott-arriva-in-italia-freestyle-libre-3-sistema-di-monitoraggio-in-continuo-del-glucosio/ 2022-07-05T14:28:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ucb-pharma-italia-entra-a-far-parte-di-federation-innovation-mind/ 2022-07-06T09:20:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/becton-dickinson-la-diagnostica-a-supporto-del-nuovo-sistema-salute/ 2022-07-07T08:19:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-firenze-il-xxvi-premio-internazionale-fair-play-menarini/ 2022-07-06T12:29:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-zero-emissioni-gas-serra-entro-il-2040/ 2022-07-06T12:41:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmindustria-marcello-cattani-e-il-nuovo-presidente/ 2022-07-06T15:15:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-lancia-il-marchio-impact-per-i-farmaci-nei-paesi-a-basso-reddito/ 2022-07-07T08:51:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eisai-biogen-decisione-fda-per-lecanemab-alzheimer-attesa-entro-il-6-gennaio-2023/ 2022-07-07T09:17:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-continua-lincertezza-post-pandemia/ 2022-07-07T12:10:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-vicina-allacquisizione-di-seagen/ 2022-07-08T16:22:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-esg-per-i-pazienti-viiv-roche-e-pfizer-e-viiv-sono-al-top/ 2022-07-08T15:14:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-accordo-per-lacquisizione-di-teneotwo/ 2022-07-08T13:07:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alexion-si-espande-in-irlanda-per-i-prodotti-biologici/ 2022-07-11T09:23:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-orfani-40-dopo-lorphan-drug-act/ 2022-07-11T15:07:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sobi-accordo-con-adc-therapeutics-per-diritti-in-ue-di-zynlonta-dlbcl/ 2022-07-11T12:31:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dai-fondatori-di-moderna-startup-focalizzata-sulle-malattie-infettive/ 2022-07-12T09:31:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cepi-al-via-ricerca-su-vaccino-ad-ampio-spettro-contro-i-coronavirus/ 2022-07-12T13:06:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-la-profilassi-con-fitusiran-riduce-i-sanguinamenti-del-61nelle-persone-affette-da-emofilia-a-o-b/ 2022-07-12T14:57:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-e-visionhealth-partnership-per-terapia-digitale-ai-pazienti-con-asma-e-bpco/ 2022-07-13T09:12:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-torna-a-lavorare-su-farmaco-sperimentale-contro-lalzheimer/ 2022-07-13T09:36:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/metaverso-e-i-rischi-per-la-privacy/ 2022-07-13T12:52:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/25449/ 2022-07-13T12:40:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-acquisisce-viacyte-per-terapia-genica-contro-il-diabete/ 2022-07-13T12:51:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novavax-ok-fda-a-vaccino-anti-covid19/ 2022-07-14T09:20:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/grunenthal-acquisisce-da-bayer-il-brand-nebido/ 2022-07-14T10:25:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bando-fondazione-roche-per-la-ricerca-indipendente-400-mila-euro-a-8-ricercatori-under-40/ 2022-07-14T12:44:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/genentech-roche-amplia-la-partnership-immuno-oncologica-con-bicycle-therapeutics/ 2022-07-14T13:06:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prevenzione-e-innovazione-per-la-salute-del-futuro-90-anni-di-gsk-in-italia/ 2022-07-14T14:10:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-nuovi-dati-positivi-per-faricimab-nella-namd/ 2022-07-14T14:22:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-accordo-con-orion-per-sviluppare-candidato-contro-il-cancro-della-prostata/ 2022-07-15T07:55:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/somministrazione-di-prodotti-biologici-nose-to-brain-la-sfida-di-chiesi/ 2022-07-15T08:31:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trial-clinici-progetto-pilota-ema-per-raccogliere-dati-grezzi/ 2022-07-15T15:46:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanitask-il-personale-del-ssn-deve-essere-valorizzato-economicamente-ma-attraverso-un-ambiente-di-lavoro-organizzato-sereno-e-stimolante/ 2022-07-15T15:12:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/consumer-health-nasce-haleon/ 2022-07-18T09:38:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuovi-antibiotici-la-ricerca-chiede-piu-coraggio-nellambito-normativo/ 2022-07-18T10:06:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/obesita-novo-nordisk-ed-eli-lilly-domineranno-il-mercato-fino-alla-fine-del-decennio/ 2022-07-18T12:26:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nestle-rinnova-limpegno-sui-farmaci-per-il-microbioma/ 2022-07-19T09:36:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/big-pharma-cresce-lattesa-per-i-risultati-del-q2-tra-accordi-e-lanci-di-farmaci/ 2022-07-19T14:25:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-e-astrazeneca-trastuzumab-deruxtecan-approvato-in-ue-per-tumore-al-seno-her2-metastatico/ 2022-07-19T14:40:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-britannica-nice-raccomanda-la-terapia-combinata-di-novartis-per-la-cura-del-cancro-della-mammella/ 2022-07-20T09:56:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/health-serie-anche-loncologia-di-precisione-nel-piu-ampio-alveo-della-one-health/ 2022-07-20T14:24:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-approva-il-jak-inibitore-ruxolitinib-per-uso-topico-per-la-vitiligine-di-incyte/ 2022-07-20T16:16:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-presenta-domanda-di-autorizzazione-allema-per-trattamento-di-profilassi-dellemicrania/ 2022-07-20T16:17:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-nel-2021-la-spesa-cresce-ancora-e-si-avvicina-a-quota-20-mld-i-dati-definitivi-di-aifa/ 2022-07-20T16:22:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-pfizer-biontech-chiede-approvazione-ad-ema-per-nuovo-vaccino-aggiornato-contro-omicron/ 2022-07-20T16:23:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-accordo-con-avista-su-terapia-genica-per-gli-occhi/ 2022-07-21T09:29:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-da-cansino-vaccino-anche-per-via-inalatoria/ 2022-07-21T13:01:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-ritira-richiesta-autorizzazione-fda-per-uso-in-monoterapia-di-tislelizumab-nsclc/ 2022-07-21T13:35:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-chiesi-per-un-futuro-piu-sano-e-sostenibile/ 2022-07-21T15:13:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oncologia-territoriale-verso-un-modello-di-gestione-extra-ospedaliero/ 2022-07-22T10:48:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-il-ceo-schwan-lascia-a-marzo-2023/ 2022-07-22T15:37:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-novartis-vendite-in-aumento-per-il-prossimo-semestre/ 2022-07-22T15:37:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-risultati-positivi-per-hyqvia-nella-cidp/ 2022-07-25T10:15:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaiolo-delle-scimmie-ema-racccomanda-estensione-vaccino-bavarian-nordic/ 2022-07-25T15:06:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sistemi-digitali-di-supporto-alle-attivita-cliniche-in-corsia-e-il-momento/ 2022-07-25T13:03:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amazon-passo-avanti-nella-sanita-acquisita-onemedical/ 2022-07-25T13:39:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ema-raccomanda-faricimab-per-edema-maculare-diabetico-e-degenerazione-maculare-umida/ 2022-07-25T14:40:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-italia-piam-completa-lacquisizione-di-bruschettini/ 2022-07-25T15:21:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-neopharmed-gentili-litaliana-valeas/ 2022-07-25T15:28:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-ok-commissione-europea-a-rinvoq-nel-trattamento-della-colite-ulcerosa-attiva-da-moderata-a-severa/ 2022-07-26T09:26:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ue-nuovo-regolamento-su-sangue-tessuti-e-cellule/ 2022-07-26T10:35:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-cinese-ottiene-in-licenza-tecnologia-per-farmaci-basati-su-rna-di-sanofi/ 2022-07-26T13:42:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/spasticita-post-ictus-il-percorso-dopo-levento-acuto-e-una-corsa-ad-ostacoli-da-camerae-sanitatis-appello-a-non-lasciare-soli-i-pazienti/ 2022-07-27T08:16:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/informatori-incontri-video-piu-efficaci-di-quelli-di-persona/ 2022-07-27T09:51:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/seagen-astellas-e-msd-buoni-risultati-per-combo-padcev-keytruda-contro-il-cancro-della-vescica/ 2022-07-27T12:29:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/innovazione-ricciardi-e-moretti-e-lunica-via-per-il-futuro-e-deve-essere-dirompente/ 2022-07-28T08:26:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-diagnostics-nice-raccomanda-luso-del-test-diagnostico-per-la-pre-eclampsia/ 2022-07-28T13:06:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-shingrix-guida-il-q2/ 2022-07-28T14:04:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/giornata-mondiale-delle-epatiti-cattani-farmindustria-la-ricerca-ha-dato-speranza-di-cura-a-molti-pazienti/ 2022-07-28T14:59:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/analisi-di-laboratorio-con-nuove-tecnologie-beckman-coulter-fino-a-15mila-test-al-giorno/ 2022-07-28T15:20:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kam-la-nuova-strategia-per-le-life-sciences/ 2022-07-29T10:15:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-accordo-di-fornitura-con-ue-per-vaccino-contro-influenza-pandemica/ 2022-07-29T10:15:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-dupixent-superstar-del-q2/ 2022-07-29T12:45:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-acquisisce-sofar-e-consolida-la-leadership-nellarea-gastrointestinale/ 2022-08-01T08:51:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/policy-brief-camerae-sanitatis-emicrania-una-patologia-sociale/ 2022-08-03T13:37:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-ok-a-evusheld-per-il-trattamento-precoce-del-covid-19-in-soggetti-a-rischio-di-progressione/ 2022-08-04T07:11:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-edoxaban-efficace-e-sicuro-nei-pazienti-con-fa-complessi-e-fragili/ 2022-08-31T15:40:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-ok-ce-a-scemblix-nella-leucemia-mieloide-cronica/ 2022-08-30T16:06:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-sandoz-sara-spin-off/ 2022-08-31T09:13:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-vaccini-antivirali-monoclonali-e-programmazione-le-armi-per-non-farsi-cogliere-impreparati/ 2022-08-31T10:52:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cdmo-un-mercato-da-130-miliardi-di-dollari-entro-il-2026/ 2022-08-31T12:57:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-cemiplimab-rimborsabile-in-italia-per-due-nuove-indicazioni/ 2022-08-31T13:31:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/national-summit-un-quadro-italiano-sul-lupus-gestione-attuale-e-progetti-futuri/ 2023-08-31T16:21:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-vaccino-bivalente-contro-rsv-efficace-negli-over-60/ 2022-09-01T10:57:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/policy-brief-camerae-sanitatis-la-gestione-dello-scompenso-cardiaco-in-epoca-di-pandemia-covid-19/ 2022-09-01T11:32:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-disco-verde-fda-ai-booster-aggiornati-di-pfizer-e-moderna/ 2022-09-01T12:25:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dr-reddy-s-accordo-con-no-profit-svizzera-per-sviluppare-farmaci-contro-le-malattie-tropicali-neglette/ 2022-09-01T12:48:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/payback-dispositivi-medici-2015-2018-per-le-aziende-un-conto-da-oltre-2-mld-di-euro/ 2022-09-01T15:35:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-acquisisce-forma-therapeutics-e-punta-al-trattamento-dellanemia-falciforme/ 2022-09-02T09:08:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biomarin-ok-ce-a-terapia-genica-per-emofilia-a-grave/ 2022-09-02T09:29:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-crescita-moderata-per-le-industrie-indiane-nel-2023/ 2022-09-02T13:20:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-lancia-in-italia-lapp-terapiu-per-monitorare-le-terapie-prescritte/ 2022-09-05T10:56:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-una-web-serie-per-raccontare-il-mieloma-mulltiplo/ 2022-09-05T12:48:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-nuovi-dati-positivi-su-keytruda-a-cinque-anni-nel-nsclc/ 2022-09-05T13:16:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-ok-fda-a-farmaco-per-malattia-rara-della-pelle/ 2022-09-05T13:44:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-da-aifa-via-libera-ai-vaccini-bivalenti-efficaci-anche-contro-varianti-omicron/ 2022-09-06T07:25:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cattani-farmindustria-inappropriato-parlare-di-di-extraprofitti-nel-pharma/ 2022-09-06T15:59:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-cambio-ai-vertici-delloncologia/ 2022-09-06T09:58:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-italia-ecco-il-nuovo-leadership-team/ 2022-09-06T10:24:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ok-fda-a-imfinzi-nel-carcinoma-delle-vie-biliari/ 2022-09-06T12:40:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-da-oms-prequalifica-a-mosquirix-vaccino-contro-la-malaria/ 2022-09-06T13:17:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-in-futuro-nuove-acquisizioni/ 2022-09-07T09:30:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-cinque-pilastri-per-i-prodotti-self-care/ 2022-09-07T13:05:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/big-pharma-brasile-mercato-ancora-non-sfruttato/ 2022-09-07T13:31:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-tumori-polmone-e-tiroide-via-libera-aifa-a-selpercatinib/ 2022-09-07T14:18:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-italia-andrea-degiorgi-nuovo-rare-bu-head/ 2022-09-07T15:21:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/crisi-energetica-costi-fuori-controllo-lallarme-della-filiera-farmaceutica/ 2022-09-08T09:19:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ricerca-clinica-pronto-lact-eu/ 2022-09-08T09:44:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-shopping-nelloncologia-acquisita-good-therapeutics/ 2022-09-08T10:10:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-menarini-nasce-il-think-thank-on-radar-lo-guidera-massimo-scaccabarozzi/ 2022-09-09T07:37:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/valneva-e-vbi-partnership-per-il-vaccino-contro-lepatite-b/ 2022-09-09T09:26:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sidemast-al-via-segnali-sulla-pelle-visite-di-screening-gratuite-per-la-cheratosi-attinica/ 2022-09-09T13:12:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-italia-frederico-da-silva-nuovo-ad/ 2022-09-12T09:09:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-mercato-usa-vaccino-anti-covid-19-vale-13-mld-di-dollari-allanno/ 2022-09-12T12:31:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biontech-progressi-nel-settore-delle-cart/ 2022-09-12T13:18:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sobi-da-aifa-rimborsabilita-per-pegcetacoplan-nella-epn/ 2022-09-12T13:39:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-carcinoma-mammario-rimborsabilita-in-italia-per-pertuzumab-e-trastuzumab-con-ialuronidasi-umana-ricombinante-per-iniezione-sottocutanea/ 2022-09-12T14:01:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-nuovi-dati-positivi-per-niraparib-nel-carcinoma-ovarico/ 2022-09-12T14:44:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-300-mln-di-dollari-per-la-produzione-di-farmaci-biologici/ 2022-09-13T09:40:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biomarin-da-aifa-via-libera-a-voxzogo-nella-terapia-dellacondroplasia/ 2022-09-13T10:19:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/usa-il-nih-lancia-due-studi-su-terapie-per-il-vaiolo-delle-scimmie/ 2022-09-13T10:36:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-italia-tornano-le-avventure-della-smagliante-ada/ 2022-09-13T12:30:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cambiamento-climatico-e-industria-farmaceutica-sfide-e-opportunita/ 2022-09-13T14:14:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cardiobreast-dragon-boat-festival-liniziativa-contro-tumore-al-seno-e-malattie-cardiovascolari/ 2022-09-13T16:21:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-partnership-con-microsoft-per-la-scoprire-nuovi-farmaci-con-lai/ 2022-09-14T09:23:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-italia-10-anni-di-impegno-contro-il-cancro/ 2022-09-14T10:29:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-servier-i-primi-50-anni-in-italia/ 2022-09-14T11:05:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/doc-acquisisce-il-portafoglio-prodotti-di-medivis/ 2022-09-14T12:11:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-e-caccia-al-nuovo-ceo/ 2022-09-15T08:39:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-vaccino-antinfluenzale-mrna-in-fase-3/ 2022-09-15T08:57:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/servier-crc-trifluridina-tipiracil-piu-bevacizumab-raggiunge-endpoint-di-sopravvivenza-nello-studio-sunlight/ 2022-09-15T14:14:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/luca-ruffini-nuovo-gm-di-amarin-italia/ 2022-09-15T14:55:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-italia-nuova-sede-nel-cuore-di-milano/ 2022-09-16T15:36:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-chmp-raccomanda-approvazione-di-nirsevimab-per-la-prevenzione-dellrsv/ 2022-09-16T09:33:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-300-milioni-di-euro-per-impianto-produzione-terapie-plasma-derivate/ 2022-09-16T10:04:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-e-nih-partnership-per-sviluppo-trattamenti-contro-le-malattie-neurodegenerative/ 2022-09-16T10:17:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bluebird-ok-fda-a-terapia-genica-contro-la-cald/ 2022-09-19T15:07:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-nel-2021-covid-ha-guidato-la-crescita/ 2022-09-19T12:47:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-oms-stende-raccomandazione-per-remdesivir/ 2022-09-19T13:11:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/theravance-buyback-delle-azioni-gsk/ 2022-09-20T13:41:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-orfani-molti-sono-oncologici/ 2022-09-20T14:01:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/doctolib-italia-cesare-guidorzi-e-il-nuovo-vice-president-hospital-public-business/ 2022-09-20T14:23:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/giornata-mondiale-dellalzheimer-limpegno-del-gruppo-roche/ 2022-09-20T15:35:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-apre-un-nuovo-centro-di-ricerca-a-san-francisco/ 2022-09-21T09:23:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ok-ce-a-combo-tixagevimab-e-cilgavimab-nel-covid-19/ 2022-09-21T10:00:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viatris-entra-nellarea-ematologica/ 2022-09-21T10:29:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dal-diabete-alle-allergie-tutte-le-potenzialita-della-ricerca-sullesposoma/ 2022-09-21T12:57:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/confindustria-dm-decreto-aiuti-bis-il-payback-mette-in-ginocchio-le-imprese/ 2022-09-21T14:18:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-ok-aifa-a-rimborsabilita-di-rinvoq-nella-spondilite-anchilosante-attiva/ 2022-09-22T09:24:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-partnership-con-cytoreason-per-ricerca-farmaci-guidata-dallai/ 2022-09-22T09:40:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/incyte-un-cortometraggio-per-conoscere-e-non-temere-la-lmc/ 2022-09-22T14:48:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/salute-sessuale-e-riproduttiva-della-donna-in-italia-ce-ancora-molta-strada-da-fare-le-riflessioni-a-camerae-sanitatis/ 2022-09-22T14:47:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/celltrion-e-abpro-insieme-per-sviluppo-anticorpo-contro-tumori-her2-positivi/ 2022-09-23T09:00:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biosimilari-ok-dellema-e-hma-a-intercambiabilita/ 2022-09-23T09:12:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-torna-la-campagna-di-sensibilizzazione-sullartrite-reumatoide-parla-piu-forte-della-tua-ar/ 2022-09-26T09:56:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-maculopatie-raggiunto-endpoint-in-due-studi-registrativi-con-aflibercept-8-mg/ 2022-09-26T10:30:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-fondazione-novo-nordisk-investira-200-mln-di-dollari-nel-computer-quantistico/ 2022-09-26T12:54:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-us-first-per-conquistare-lamerica/ 2022-09-26T13:35:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-tezepelumab-approvato-nellunione-europea-per-il-trattamento-dellasma-grave/ 2022-09-26T15:57:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotecnologie-cattani-farmindustria-serve-strategia-nazionale/ 2022-09-26T16:00:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-trattamento-adiuvante-con-nivolumab-migliora-sopravvivenza-libera-da-recidiva-nel-melanoma/ 2022-09-26T16:05:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/stryker-isabella-mandelli-nuova-vice-presidente-e-ad-della-sede-italiana/ 2022-09-27T09:29:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-e-sangamo-riprendono-studio-su-terapia-genica-per-emofilia-a/ 2022-09-27T09:58:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nasce-dico-sanita-network-di-digitalizzazione-collaborativa-in-sanita-promosso-da-bayer/ 2022-09-27T10:32:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-un-gruppo-di-investimento-interessato-allacquisizione/ 2022-09-28T08:59:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizerbiontech-eua-a-fda-per-vaccino-bivalente-contro-omicron-nei-bambini-511/ 2022-09-28T15:07:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-arriva-in-italia-satralizumab-primo-trattamento-sottocutaneo-specifico-per-la-neuromielite-ottica/ 2022-09-28T11:57:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sobi-equipaggio-con-itp-alla-regata-millevele-di-genova/ 2022-09-28T15:56:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-ed-eisai-buoni-risultati-da-farmaco-sperimentale-per-lalzheimer/ 2022-09-29T15:46:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-italia-tra-nomine-nel-senior-management-team/ 2022-09-29T12:47:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eepia-in-europa-nuovo-modello-per-ricerca-e-sviluppo-antibiotici/ 2022-09-29T14:43:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-accordo-con-spero-therapeutics-per-licenza-antibiotico-cuti/ 2022-09-29T14:09:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-concorso-per-aiutare-chi-vuole-fare-informazione-nellanemia-da-insufficienza-renale-cronica/ 2022-09-30T07:55:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nasce-kenvue-la-spinout-di-johnson-johnson-dedicata-alla-consumer-health/ 2022-09-30T15:18:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-approva-farmaco-contro-la-sla/ 2022-09-30T12:00:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-sanita-e-il-nuovo-governo-presa-in-carico-del-tema-salute-pnrr-partnership-ma-anche-limpegno-a-sensibilizzare-sulla-cultura-della-donazione-di-sangue-intervista-a-annarita-egidi-gener/ 2022-09-30T16:08:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/herpes-zoster-gli-esperti-over-65-e-malati-cronici-si-proteggano-con-il-nuovo-vaccino/ 2022-09-30T15:57:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/doctolib-amplia-la-sua-offerta-con-lacquisizione-di-vettore-rinascimento/ 2022-10-03T09:36:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nobel-per-la-medicina-2022-a-svante-paabo-padre-della-paleogenomica/ 2022-10-03T11:43:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-via-allo-studio-globale-di-fase-iii-del-vaccino-per-rsv/ 2022-10-03T13:35:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-e-crispr-therapeutics-pronto-farmaco-tecnologia-di-editing-genico-per-falcemia-e-beta-talassemia/ 2022-10-03T15:41:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ibsa-piano-di-investimenti-e-nuovo-quartier-generale-a-lodi/ 2022-10-03T14:20:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipsen-patrizia-olivari-nuovo-presidente-e-ad/ 2022-10-04T08:40:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alexion-astrazeneca-acquisisce-logicbio-therapeutics-specializzata-nellediting-genetico/ 2022-10-04T10:17:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-un-francobollo-per-celebrare-i-125-anni-di-attivita-in-italia/ 2022-10-04T13:38:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-accordo-con-ventus-per-sviluppo-inibitori-nlrp3/ 2022-10-04T13:45:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/marcello-cattani-alla-guida-del-club-sante/ 2022-10-04T15:00:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regione-lazio-e-novartis-insieme-per-la-prevenzione-delle-malattie-cardiovascolari/ 2022-10-04T15:40:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-nuovo-colpo-acquisita-biohaven/ 2022-10-05T14:58:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/incyte-acquisisce-villaris-e-si-espande-nella-dermatologia/ 2022-10-05T09:16:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-italia-e-regione-friuli-venezia-giulia-per-costruire-la-medicina-del-futuro/ 2022-10-05T09:46:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-e-astrazeneca-da-fondazione-onda-la-foto-del-vissuto-e-dei-bisogni-delle-donne-con-tumore-al-seno-her2/ 2022-10-05T12:41:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-diagnostics-arriva-in-italia-il-test-elecsys-igra-sarscov2/ 2022-10-06T08:49:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-nuove-evidenze-per-lanti-pd1-jemperli/ 2022-10-06T13:07:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biohaven-leredita-dopo-lacquisizione-di-pfizer/ 2022-10-06T13:53:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanita-scienza-salute-le-sfide-per-il-futuro-al-commonground-del-maker-fair-di-roma/ 2022-10-10T08:28:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-pfizer-e-biontech-arruolano-gli-avengers-della-marvel/ 2022-10-07T09:17:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/associazioni-pfizer-al-primo-posto-tra-le-big-pharma-per-centralita-del-paziente/ 2022-10-07T14:21:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-un-presidente-per-le-partnership-strategiche-e-lespansione-aziendale/ 2022-10-07T09:42:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sistemi-di-identificazione-microbica-mercato-in-espansione/ 2022-10-07T14:15:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/polifarma-presentato-il-primo-candidato-digital-therapeutic-per-lipertensione-arteriosa/ 2022-10-07T14:12:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cdmo-per-farmaci-orali-mercato-in-crescita-per-il-prossimo-decennio/ 2022-10-10T09:39:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-un-altro-colpo-acquisita-global-blood-therapeutics/ 2022-10-10T09:53:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-partnership-con-mirecule-per-ricerca-e-sviluppo-arc-nella-distrofia-muscolare/ 2022-10-10T12:39:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-nice-raccomanda-ozanimod-per-il-trattamento-delle-forme-moderate-o-gravi-di-colite-ulcerosa/ 2022-10-10T12:58:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ucb-fenfluramina-ottiene-rimborsabilita-in-italia-per-sindrome-di-dravet/ 2022-10-10T14:58:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viatris-tutor-dellevento-la-salute-mentale-dei-giovani-protagonista-del-festival-dello-sviluppo-sostenibile-2022/ 2022-10-10T16:27:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-collaborazione-con-nazioni-unite-per-educare-sulla-carenza-di-plasma/ 2022-10-11T10:05:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-tumori-da-standford-una-ricerca-rivoluzionaria/ 2022-10-11T16:52:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/leo-pharma-campagna-globale-di-sensibilizzazione-sulla-da/ 2022-10-11T16:52:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rapporto-gimbe-sul-ssn-politica-dei-tagli-finita-ma-finanziamento-ssn-resta-insufficiente/ 2022-10-11T14:36:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trapianti-esperti-a-roma-investire-su-assistenza-post-intervento/ 2022-10-11T16:08:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viatris-arriva-in-italia-danaparoid-sodico-per-la-hit/ 2022-10-12T17:09:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/si-conclude-a-romacardiobreast-dragon-boat-festival-liniziativa-contro-tumore-al-seno-e-malattie-cardiovascolari/ 2022-10-13T07:51:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-ancora-risultati-postivi-per-il-vaccino-rsv-dallo-studio-aresvi006/ 2022-10-13T08:27:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-italia-ed-engineering-accordo-per-rispondere-alle-sfide-della-missione-6-del-pnrr/ 2022-10-13T12:27:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-nuovi-dati-di-efficacia-per-dupilumab-nelleoe/ 2022-10-13T13:07:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-con-biosimilari-risparmi-per-21-mld-di-dollari-negli-ultimi-sei-anni-in-usa/ 2022-10-13T13:36:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-e-moderna-partnership-per-vaccino-antitumorale-a-mrna/ 2022-10-13T14:30:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rs-nuova-iniziativa-per-calcolare-limpronta-di-carbonio-delle-sperimentazioni-cliniche/ 2022-10-14T09:02:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-partnership-con-surrozen-per-candidato-malattie-della-retina/ 2022-10-14T09:18:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-geniche-e-malattie-ultra-rare-la-fda-cerca-soluzioni-per-il-mercato/ 2022-10-14T16:15:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novavax-risultati-positivi-per-vaccino-covid-come-booster-e-per-vaccino-combinato-covid-influenza/ 2022-10-14T13:27:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/policy-brief-camerae-sanitatis-oncoematologia-la-sfida-delle-cronicita/ 2022-10-14T15:14:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nice-al-via-collaborazione-internazionale-su-hta/ 2022-10-17T15:22:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-sciences-bandi-di-ricerca-63-progetti-premiati-con-oltre-1-milione-di-euro/ 2022-10-17T11:16:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-a-capo-di-progetto-pilota-per-ridurre-gli-sprechi-nella-digital-health/ 2022-10-17T13:17:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-ha-voglia-di-crescere-lazienda-punta-sulla-gastroenterologia/ 2022-10-18T08:45:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-per-i-pazienti-affetti-da-rinosinusite-cronica-con-poliposi-nasale-ce-omalizumab/ 2022-10-18T09:48:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oraganon-celebra-le-donne-con-una-serie-di-murales/ 2022-10-18T15:00:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-e-tempus-accordo-per-accelerare-la-ricerca-e-lo-sviluppo-dei-farmaci/ 2022-10-18T13:34:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-ok-chmp-al-vaccino-contro-la-dengue-per-i-bambini/ 2022-10-18T13:46:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alexion-astrazeneca-ok-aifa-a-rimborsabilita-eculizumab-negli-adulti-con-miastenia-gravis-generalizzata/ 2022-10-19T10:12:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-ecco-i-vincitori-del-premio-letterario-angelo-zanibelli-la-parola-che-cura/ 2022-10-19T10:33:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-ancora-shopping-nel-biotech-acquisita-forma-therapeutics/ 2022-10-19T12:43:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kite-gilead-ok-ce-a-yescarta-nel-linfoma-diffuso-a-grandi-cellule-b/ 2022-10-19T13:09:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/policy-brief-camerae-sanitatis-neuroscienze-la-sfida-di-oggi/ 2022-10-19T16:03:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-italia-e-on-line-gipointit-sito-dedicato-a-chi-convive-con-una-malattia-infiammatoria-cronica-dellintestino/ 2022-10-20T10:54:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-acquisisce-akouos-sviluppatore-di-terapie-geniche-per-contrastare-la-perdita-delludito/ 2022-10-20T12:22:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-partnership-con-macrogenics-per-lo-sviluppo-di-anticorpi-bispecifici/ 2022-10-20T15:24:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-punta-sui-farmaci-anticorpali-acquisita-la-biotech-specializzata-djs/ 2022-10-21T09:27:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-verso-le-terapie-cart-di-seconda-generazione-collaborazione-con-startup-californiana/ 2022-10-21T09:47:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/almeno-10-anni-di-protezione-con-il-vaccino-ricombinante-contro-lherpes-zoster/ 2022-10-21T15:22:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/orazio-schillaci-e-il-nuovo-ministro-della-salute/ 2022-10-21T16:10:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/policy-brief-camerae-sanitatis-la-riabilitazione-post-ictus-lapproccio-multidisciplinare/ 2022-10-24T12:15:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-e-fujifilm-focus-sulla-campagna-screening-routine-la-prevenzione-come-rituale/ 2022-10-24T13:24:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oltre-le-cart-terapie-cellulari-in-vivo/ 2022-10-24T14:12:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ue-nuovo-quadro-normativo-per-gli-appalti-congiunti/ 2022-10-24T14:44:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bd-ospedale-fracastoro-di-san-bonifacio-con-il-sistema-ads-distribuzione-del-farmaco-informatizzata/ 2022-10-24T15:24:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-dai-dati-real-world-conferme-per-bicftctaf/ 2022-10-25T10:55:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/servier-obiettivi-2030-con-una-nuova-brand-identity/ 2022-10-25T11:03:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/future-pandemie-equo-accesso-ai-vaccini-con-la-dichiarazione-di-berlino/ 2022-10-25T13:15:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bourla-ceo-pfizer-il-2023-sara-un-anno-cruciale/ 2022-10-25T13:52:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanita-digitale-per-4-medici-italiani-su-5-e-fondamentale-per-migliorare-lattivita-lavorativa/ 2022-10-25T14:50:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-ok-fda-a-teclistamab-nel-mieloma-multiplo-recidivato-o-refrattario/ 2022-10-26T09:36:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-partnership-con-biotech-usa-per-terapie-geniche/ 2022-10-26T11:51:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cavaleri-ema-nuova-ondata-covid-in-arrivo/ 2022-10-26T14:58:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-trattamento-precoce-con-ocrelizumab-riduce-progressione-sm/ 2022-10-27T09:13:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-nasce-ifight-il-primo-portale-dedicato-alle-infezioni-fungine-invasive/ 2022-10-27T09:50:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-social-media-e-canali-digitali-le-linee-guida-di-ifpma-e-efpia/ 2022-10-27T13:20:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cattani-farmindustria-e-il-momento-di-avere-una-cabina-di-regia-forte-per-la-sanita/ 2022-10-27T17:40:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-nuovo-governo-e-la-sanita-a-sanitalk-i-timori-e-gli-auspici-dei-professionisti/ 2022-10-28T09:25:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-outsourcing-in-aumento-anche-nel-2023/ 2022-10-28T09:43:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-partnership-con-biomed-x-per-ai-nello-sviluppo-farmaci/ 2022-10-28T10:04:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-finisce-lera-frazier-rob-davis-ceo-e-presidente/ 2022-10-28T13:32:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-italia-50-anni-dello-stabilimento-di-origgio/ 2022-10-28T15:19:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-si-rafforza-nella-cardiologia-acquisita-abiomed-per-166-mld-di-dollari/ 2022-11-02T10:31:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-francesca-micheli-alla-guida-degli-stabilimenti-produttivi-di-rieti-e-pisa/ 2022-11-02T10:47:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-q3-allinsegna-di-dupixent-e-dei-vaccini-antinfluenzali/ 2022-11-03T10:17:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/leuropa-accelera-sulla-digitalizzazione-con-darwin-eu/ 2022-11-02T13:55:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dati-a-lungo-termine-del-vaccino-anti-hz-confortanti-intervista-a-pallavicini/ 2022-11-03T11:11:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-previsioni-brillanti-per-la-fine-dellanno/ 2022-11-03T10:36:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/clima-il-biofarmaceutico-e-sopra-alla-media-nella-riduzione-di-emissioni/ 2022-11-03T13:31:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/policy-brief-camerae-sanitatis-la-tutela-della-salute-della-donna/ 2022-11-04T07:27:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-ok-ce-a-nirsevimab-per-la-prevenzione-dellrsv-nei-neonati-e-bambini/ 2022-11-04T10:33:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-taglia-le-previsioni-di-vendita-del-vaccino-covid/ 2022-11-04T12:47:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/osteoartrite-un-mercato-da-quasi-4-mld-di-dollari-entro-il-2031/ 2022-11-04T13:23:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-torna-research-to-care-premio-per-valorizzare-la-ricerca-focus-di-questanno-e-il-nsclc/ 2022-11-07T13:53:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-la-visite-dei-ceo-tedeschi-in-cina/ 2022-11-07T16:34:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-e-biontech-vantaggi-del-nuovo-booster-anti-covid-rispetto-al-vaccino-originale/ 2022-11-07T15:16:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-italia-emanuel-morlino-e-il-nuovo-finance-head/ 2022-11-08T10:34:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viatris-entra-nel-settore-delloftalmologia-con-due-acquisizioni/ 2022-11-08T13:14:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/equivalenza-terapeutica-di-farmaci-con-principi-attivi-diversi-le-proposte-dellexpert-opinion/ 2022-11-08T15:32:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-scommette-su-olpasiran-per-il-cardiovascolare/ 2022-11-08T16:08:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-nice-racccomanda-keytruda-nel-carcinoma-mammario-triplo-negativo/ 2022-11-09T16:07:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alzheimer-primo-studio-clinico-virtuale-esamina-risultati-a-lungo-termine-di-aducanumab-e-donanemab/ 2022-11-09T13:07:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/survey-abbott-solo-il-39-degli-italiani-soddisfatti-di-come-e-stata-effettuata-la-diagnosi-di-malattia-vascolare-il-ruolo-fondamentale-della-tecnologia/ 2022-11-09T14:51:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-potenzia-produzione-europea-di-penicillina/ 2022-11-10T10:40:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-accordo-con-biotech-cinese-per-rs-farmaci-con-intelligenza-artificiale/ 2022-11-10T16:21:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nice-ok-a-terapie-cognitivo-comportamentali-digitali/ 2022-11-11T13:57:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-christopher-viehbacher-ex-sanofi-e-il-nuovo-ceo/ 2022-11-11T14:29:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-covid-chmp-dellema-raccomanda-approvazione-vidprevtyn-beta-come-vaccino-di-richiamo/ 2022-11-11T16:00:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-ok-ce-a-livtencity-nella-cmw-post-trapianto-refrattaria/ 2022-11-14T10:59:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ottima-performance-nel-q3/ 2022-11-14T14:04:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-covid-anche-in-usa-focus-su-evusheld/ 2022-11-15T13:53:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-un-diario-di-bordo-per-non-perdere-di-vista-la-bpco/ 2022-11-15T14:17:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-dose-di-richiamo-contro-omicron-meglio-del-vaccino-originale/ 2022-11-15T14:49:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-accordo-con-biotech-usa-per-scoperta-small-molecules/ 2022-11-16T11:08:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/congresso-ash-2022-focus-su-linfoma-e-mieloma-multiplo/ 2022-11-16T16:28:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/access-to-medicine-index-gsk-in-testa-per-lottava-volta-consecutiva/ 2022-11-16T16:47:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-in-vendita-le-unit-di-oftalmologia-e-malattie-respiratorie/ 2022-11-17T13:39:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-italia-presentato-a-roma-il-bilancio-di-sostenibilita-dei-siti-di-rieti-e-pisa/ 2022-11-17T16:34:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/igba-le-linee-guide-oms-2022-migliorano-laccesso-ai-biosimilari/ 2022-11-17T14:48:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-e-astrazeneca-chmp-raccomanda-approvazione-di-trastuzumab-deruxtecan-per-pazienti-pretrattati-con-carcinoma-gastrico-avanzato-her2/ 2022-11-18T11:01:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alfasigma-inaugurato-nello-stabilimento-di-alanno-il-nuovo-reparto-sterile-4/ 2022-11-20T17:30:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/anche-regeneron-punta-ai-farmaci-antitumorali-a-doppio-bersaglio/ 2022-11-18T13:27:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-biontech-via-allo-studio-del-nuovo-vaccino-covid/ 2022-11-18T13:56:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-ok-aifa-a-pralsetinib-nel-nsclc-avanzato-ret-positivo/ 2022-11-21T17:01:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-global-vaccine-market-report-2022-obiettivo-equa-distribuzione-ancora-da-raggiungere/ 2022-11-21T17:01:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-fda-approva-primo-farmaco-che-ritarda-il-diabete-di-tipo-1/ 2022-11-21T15:18:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-ce-approva-sutimlimab-per-il-trattamento-dellanemia-emolitica-nei-pazienti-adulti-con-malattia-da-agglutinine-fredde/ 2022-11-21T16:11:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/linfoma-diffuso-a-cellule-b-aifa-raccomanda-la-rimborsabilita-di-tafasitamab/ 2022-11-22T08:16:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-richard-francis-ex-numero-uno-di-sandoz-nuovo-ceo-dal-primo-gennaio-2023/ 2022-11-22T10:57:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-acquisisce-imago-biosciences/ 2022-11-22T11:19:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/big-pharma-fuga-da-twitter/ 2022-11-23T12:35:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-corsa-a-ostacoli-verso-una-nuova-classe-di-antibiotici/ 2022-11-23T13:04:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prima-e-oltre-il-farmaco-la-visione-di-novartis-italia-nel-suo-primo-report-di-sostenibilita/ 2022-11-24T16:50:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-lo-caputo-unifg-monoclonali-proteggono-anziani-e-fragili-da-malattia/ 2022-11-24T11:09:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-potenzia-la-produzione-di-farmaci-in-danimarca/ 2022-11-24T13:38:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/recordati-inaugurato-playground-pubblico-nel-quartiere-san-siro-di-milano/ 2022-11-24T16:59:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nasce-bioneers-pionieri-per-le-scienze-della-vita/ 2022-11-24T20:18:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-nasce-il-qig-per-favorire-linnovazione-dei-farmaci/ 2022-11-25T13:30:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mirati-la-biotech-oncologica-che-fa-gola-a-molte-big/ 2022-11-25T13:27:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/grunenthal-acquisisce-portafoglio-farmaci-consolidati-kyowa-kirin/ 2022-11-28T13:42:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/intelligenza-artificiale-ecco-le-aziende-leader/ 2022-11-28T14:10:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-prove-di-riforma/ 2022-11-28T14:42:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-diagnostics-studio-strong-hf-sullo-scompenso-cardiaco-acuto-interrotto-per-dimostrata-efficacia-superiore/ 2022-11-29T10:19:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-accordo-con-biotech-uk-per-sviluppo-terapia-bpco/ 2022-11-29T11:38:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/telemedicina-robotica-e-domotica-tre-parole-per-la-sanita-del-2030/ 2022-11-29T14:02:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-passa-lemendamento-al-decreto-che-elimina-la-figura-del-dg/ 2022-11-30T17:33:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-acquisisce-neogene/ 2022-11-30T13:02:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/uk-primo-studio-clinico-adattivo-per-linfluenza/ 2022-11-30T13:22:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/best-practice-per-la-gestione-territoriale-del-covid-19/ 2022-11-30T15:51:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jacopo-andreose-nuovo-ceo-di-angelini-pharma/ 2022-11-30T17:03:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lindiana-biocon-completa-lacquisizione-dei-biosimilari-di-viatris/ 2022-12-01T10:40:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanitalk-9-pnrr-e-dm77-i-molti-dubbi-degli-stakeholder-anche-se-permane-un-certo-ottimismo/ 2022-12-01T10:54:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-eisai-lecanemab-rallenta-il-declino-cognitivo-nellad/ 2022-12-01T11:12:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-hiv-ok-ce-a-biktavry-a-basso-dosaggio-per-uso-pediatrico/ 2022-12-01T13:25:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gyrus-capital-acquisisce-il-40-di-consulcesi-group-nasce-la-prima-piattaforma-digitale-internazionale-dellhealthcare/ 2022-12-01T17:32:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-inizia-lera-duato/ 2022-12-02T09:29:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/horizon-therapeutics-la-biotech-di-dublino-che-fa-gola-a-molte-big-pharma/ 2022-12-02T09:47:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novavax-covid-19-il-vaccino-nuvaxovid-nellelenco-oms-per-luso-di-emergenza/ 2022-12-02T10:12:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-non-vaccinali-a-mrna-un-mercato-da-2-mld-di-dollari-entro-il-2028/ 2022-12-02T14:20:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccines-europe-efpia-in-europa-si-spende-poco-per-le-vaccinazioni/ 2022-12-05T16:56:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/carcinoma-endometriale-analisi-ad-interim-mostra-i-benefici-di-dostarlimab/ 2022-12-05T17:00:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-accetta-la-domanda-di-autorizzazione-a-immissione-in-commercio-di-momelotinib/ 2022-12-05T13:38:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-ibsa-luca-crippa-e-il-nuovo-chief-commercial-officer/ 2022-12-12T11:17:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/zentiva-acquisisce-i-brand-zerinol-e-soluzione-schoum-da-sanofi/ 2022-12-06T11:38:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-biontech-eua-a-fda-per-nuovo-vaccino-covid-ai-bambini/ 2022-12-06T13:40:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cdmo-italia-si-conferma-paese-leader-in-europa-con-fatturato-vicino-ai-27-miliardi/ 2022-12-06T16:43:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanita-digitale-appello-per-un-tavolo-permanente-guidato-dal-ministero-della-salute/ 2022-12-07T10:18:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ospedale-sacco-punto-di-riferimento-vaccinale-per-larea-milanese/ 2022-12-07T11:09:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/valneva-ottimi-risultati-per-il-vaccino-contro-la-chikungunya/ 2022-12-07T13:38:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-ionis-ok-ema-a-immissione-in-commercio-di-tofersen-nella-sla-da-superossido-dismutasi-1/ 2022-12-07T14:09:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-cala-la-capitalizzazione-di-mercato-nel-q3/ 2022-12-08T09:42:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-lancia-ms-kare-per-supportare-i-pazienti-con-sclerosi-multipla-nella-gestione-domiciliare-delle-cure/ 2022-12-12T10:39:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/polifarma-e-pharmanovia-partnership-di-distribuzione-per-litalia/ 2022-12-12T13:22:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/catalent-apre-mega-sito-per-produzione-mondiale-di-terapie-cellulari/ 2022-12-12T18:34:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-biontech-ok-mhra-a-comirnaty-nei-bambini-tra-i-6-mesi-e-i-4-anni/ 2022-12-12T14:38:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-ok-ce-a-vaccino-contro-la-dengue/ 2022-12-12T17:15:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novavax-autorita-svizzere-evidenziano-efficacia-nuvaxovid-contro-sottovarianti-omicron/ 2022-12-12T17:48:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/big-deal-2022-amgen-acquisisce-horizon-therapeutics-per-28-mld-di-dollari/ 2022-12-13T12:49:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-accordo-di-collaborazione-con-entrada-therapeutics-per-malattia-rara/ 2022-12-13T13:14:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/26536/ 2022-12-13T16:31:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-lacido-bempedoico-riduce-il-rischio-di-gravi-eventi-cardiovascolari-in-pazienti-affetti-da-ipercolesterolemia/ 2022-12-13T16:34:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-i-piani-per-il-2023/ 2022-12-14T13:08:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-4-mld-di-dollari-per-farmaco-sperimentale-di-nimbus/ 2022-12-14T17:40:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-nuovo-quartier-generale/ 2022-12-14T17:40:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nasce-la-fondazione-consulcesi-la-mission-e-il-sostegno-alle-fasce-piu-vulnerabili/ 2022-12-14T14:25:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-ok-ce-a-pluvicto-per-il-trattamento-del-cancro-alla-prostata/ 2022-12-14T14:40:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-riforma-aifa-e-legge-abolita-la-figura-del-direttore-generale/ 2022-12-14T17:41:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-medtech-gabriele-fischetto-e-il-nuovo-ad/ 2022-12-14T16:41:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alzheimer-il-futuro-della-cura-passa-per-i-biomarker/ 2022-12-15T13:54:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ok-del-senato-al-riordino-del-ministero-della-salute/ 2022-12-15T14:25:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-msd-combo-vaccino-mrna-e-keytruda-migliora-la-sopravvivenza-nel-melanoma/ 2022-12-15T14:40:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/social-media-nel-pharma-e-tempo-dei-dol-influencer/ 2022-12-15T15:27:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/angelini-pharma-ema-estende-indicazione-dalbavancina-a-pazienti-pediatrici-con-absssi/ 2022-12-16T10:59:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-la-commissione-europea-approva-dupixent-per-la-prurigo-nodularis/ 2022-12-16T11:34:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sclerosi-multipla-terapie-ad-alta-efficacia-subito-per-ritardare-la-progressione-della-malattia-le-riflessioni-del-piemonte-al-primo-regional-summit-di-sics/ 2022-12-16T14:58:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-50-anni-di-investimenti-in-italia-il-valore-del-partenariato/ 2022-12-16T19:34:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-chmp-dellema-raccomanda-approvazione-di-dupilumab-per-lesofagite-eosinofila-nella-ue/ 2022-12-19T12:47:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-per-alzheimer-un-mercato-da-68-mld-di-dollari-entro-il-2032/ 2022-12-19T13:14:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/les-il-futuro-e-nelle-terapie-cellulari/ 2022-12-19T14:08:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmindustria-e-federchimica-premiano-le-migliori-esperienze-aziendali-di-responsabilita-sociale/ 2022-12-20T11:21:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ce-ok-a-prima-prima-terapia-allogenica-a-base-di-cellule-t/ 2022-12-20T16:36:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/2022-lanno-del-rebranding-per-le-biotech/ 2022-12-20T13:28:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ma-2023-ci-sara-ancora-spazio-nonostante-la-recessione/ 2022-12-20T14:13:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bvvbvb/ 2022-12-20T15:58:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/congresso-sifo-biosimilari-criteri-per-limplementazione-di-gare-qualita-prezzo-2/ 2022-12-21T08:07:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/con-tmunity-therapeutics-gilead-si-rafforza-nelle-terapie-cart/ 2022-12-21T13:25:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-ok-chmp-dellema-per-il-booster-bivalente-anti-covid19-nei-bambini/ 2022-12-21T16:59:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/drug-discovery-servier-e-opm-lanciano-federaidd/ 2022-12-21T14:03:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-e-astrazeneca-via-libera-in-europa-a-trastuzumab-deruxtecan-nel-carcinoma-gastrico-avanzato-her2/ 2022-12-21T15:23:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-produrra-farmaci-innovativi-ad-abu-dhabi/ 2022-12-22T09:48:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-cede-a-roche-farmaco-anticorpale-bispecifico-per-il-linfoma/ 2022-12-22T10:56:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumori-del-sangue-con-car-t-75-risposte-complete-nel-mieloma-multiplo/ 2022-12-22T18:13:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-accordo-con-biotech-cinese-per-ampliare-la-pipeline-adc/ 2022-12-23T10:56:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lanno-che-verra-lai-sara-il-segno-dominante/ 2022-12-23T11:22:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-nuovo-accordo-con-biotech-olandese-per-editing-rna/ 2022-12-23T16:56:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/confindustria-dm-e-fifo-confcommercio-mai-fatto-accordi-sul-payback/ 2023-01-02T11:02:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eisai-e-biogen-via-libera-a-lecanemab-nel-trattamento-dellalzheimer/ 2023-01-09T15:42:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/j-e-lora-di-kenvue/ 2023-01-09T16:41:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/2023-anno-di-crescita-per-le-big-pharma/ 2023-01-09T15:26:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biontech-partnership-con-nhs-per-terapie-antitumorali-personalizzate/ 2023-01-09T12:49:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/grunenthal-italia-la-nuova-gm-e-laura-premoli/ 2023-01-09T15:21:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-accordo-da-40-milioni-di-dollari-con-wuxi-biologics-per-anticorpi-multispecifici/ 2023-01-10T11:17:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-focus-su-5-aree-terapeutiche-ma-niente-cessioni-unit-di-oftalmologia-e-malattie-respiratorie/ 2023-01-10T13:19:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-italia-arianna-gregis-country-division-head-della-divisione-pharmaceuticals/ 2023-01-10T13:39:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/csl-vifor-nasce-renal-care-piattaforma-online-dedicata-alle-malattie-renali-croniche/ 2023-01-10T14:08:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-astrazeneca-e-ipsen-prime-acquisizioni-dellanno/ 2023-01-10T14:45:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bourla-ceo-pfizer-ecco-la-roadmap-per-il-2030/ 2023-01-11T10:58:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dal-volume-al-valore-il-new-deal-del-pharma-indiano/ 2023-01-11T13:07:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-punta-forte-su-kerendia-e-nubeqa/ 2023-01-11T13:53:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/insilico-ok-studio-clinico-di-fase-1-per-primo-farmaco-sviluppato-da-ai/ 2023-01-11T14:27:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-contro-lalzheimer-e-il-turno-di-alzecure/ 2023-01-12T10:25:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biontech-accordo-con-instadeep-su-ai-e-apprendimento-automatico/ 2023-01-12T10:46:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dispositivi-medici-in-gazzetta-il-decreto-che-proroga-al-30-aprile-i-pagamenti-per-le-aziende/ 2023-01-12T10:58:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eisai-e-biogen-domanda-per-lecanemab-anche-nella-ue/ 2023-01-12T11:33:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/2023-i-magnifici-sette-potenziali-blockbuster/ 2023-01-12T15:08:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-quattro-nuovi-farmaci-per-il-2023/ 2023-01-13T10:54:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-sara-lanno-di-altuviiio-e-beyfortus/ 2023-01-13T11:31:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viehbacher-ceo-biogen-sara-un-anno-impegnativo-per-una-crescita-sostenibile/ 2023-01-13T16:12:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-italia-federico-villa-nuovo-associate-vice-president-corporate-and-public-affairs/ 2023-01-16T13:36:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-punta-su-uk-e-aderisce-allassociazione-delle-pharma-britanniche/ 2023-01-16T09:41:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ok-chmp-per-autosommistrazione-di-tezspire-negli-over-12/ 2023-01-16T16:40:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-via-libera-fda-a-rybelsus-come-terapia-di-prima-linea-nel-diabete/ 2023-01-16T16:39:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-750-milioni-di-dollari-per-il-fondo-sanofi-ventures/ 2023-01-17T11:23:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ok-fda-ad-airsupra-nuovo-trattamento-per-lasma/ 2023-01-17T14:10:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-di-tipo-2-come-cambia-il-mercato/ 2023-01-17T15:29:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-michela-babarossa-la-responsabilita-del-legal-compliance-officer-it-del-gruppo-grunenthal-italia/ 2023-01-17T16:05:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-italia-al-via-ibd-cooking-channel-webserie-dedicata-a-chi-vive-con-malattie-croniche-intestinali/ 2023-01-18T17:04:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-amplia-il-suo-impegno-no-profit/ 2023-01-18T11:31:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-rinvoq-e-skyrizi-per-la-crescita-dei-prossimi-anni/ 2023-01-18T17:36:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/servier-e-taiho-oncology-dallo-studio-sunlight-ottimi-risultati-per-trifluridina-tipiracil-e-bevacizumab-nel-mcrc/ 2023-01-18T14:31:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-nubi-dellinflazione-ancora-dense-per-il-2023/ 2023-01-18T17:00:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-acquisisce-blackford-analysis-per-limaging-digitale/ 2023-01-19T16:57:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-il-vaccino-a-mrna-per-lrsv-efficace-negli-over-60/ 2023-01-19T11:37:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-acquisisce-impianto-di-sostanze-biologiche-dalla-britannica-abzena/ 2023-01-19T16:57:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/antibiotico-resistenza-da-aifa-nuove-indicazioni-per-combatterla/ 2023-01-19T16:09:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sun-pharmaceutical-acquisisce-concert-pharmaceutical/ 2023-01-20T13:33:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-combo-tecentriq-avastin-riduce-rischio-recidiva-del-tumore-al-fegato/ 2023-01-22T16:37:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/seagen-ok-fda-a-tukysa-per-il-trattamento-del-tumore-del-colon-retto/ 2023-01-20T14:18:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-schillaci-sara-annarosa-marra-il-nuovo-direttore/ 2023-01-22T16:23:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-lancia-next-gen-scholarship/ 2023-01-23T10:58:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipsen-buoni-risultati-per-onivyde-nel-cancro-aggressivo-del-pancreas/ 2023-01-23T11:34:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bancel-ceo-moderna-espansione-globale-con-aumento-della-produzione/ 2023-01-23T14:04:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-italia-paola-pirotta-e-la-nuova-ad-a-michele-perrino-un-incarico-internazionale/ 2023-01-23T14:51:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/big-pharma-sconti-sui-farmaci-e-la-cina-e-piu-vicina/ 2023-01-23T15:22:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-accordo-da-oltre-un-mld-di-dollari-per-i-diritti-commerciali-di-fruquintinib-al-di-fuori-della-cina/ 2023-01-24T13:55:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/europa-non-solo-antibiotici-problemi-anche-per-i-generici/ 2023-01-24T17:12:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/evaxion-biotech-fast-track-a-immunoterapia-in-combinazione-con-keytruda-msd/ 2023-01-24T17:22:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-8-milioni-di-dollari-per-studi-clinici-basati-sulla-diversita/ 2023-01-24T15:25:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/duato-ceo-j-obiettivo-60-mld-di-dollari-entro-il-2025/ 2023-01-25T11:08:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-italia-lauri-lindgren-e-il-nuovo-presidente-e-ad/ 2023-01-25T14:41:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/2023-anno-di-svolta-per-le-immunoterapie/ 2023-01-25T13:05:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-da-aifa-rimborsabilita-per-skyrizi-nellartrite-psoriasica-attiva/ 2023-01-25T13:24:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-e-crispr-ema-ha-accolto-la-domanda-di-autorizzazione-allimmissione-in-commercio-per-exacel/ 2023-01-25T13:46:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-investimento-da-450-milioni-di-dollari-in-sito-produttivo-usa/ 2023-01-25T14:10:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-fda-valuta-cambiamento-nella-strategia-di-vaccinazione-anti-covid19/ 2023-01-26T10:50:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sobi-annalisa-adani-nuova-vp-e-general-manager/ 2023-01-26T15:16:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lonza-per-il-2023-crescita-high-single-digit/ 2023-01-26T16:19:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/per-le-nuove-assunzioni-il-pharma-guarda-alla-robotica/ 2023-01-26T15:57:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vir-biotechnology-scangos-lascia-da-bayer-attiva-marianne-de-backer/ 2023-01-26T14:24:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kite-gilead-il-nice-raccomanda-yescarta/ 2023-01-27T11:02:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-accordo-con-astellas-su-antimicotico/ 2023-01-27T11:19:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biotech-tra-tempeste-inflazionistiche-e-ripresa-delle-partnership/ 2023-01-27T13:58:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ai-in-ospedale-si-ma-come/ 2023-01-27T14:42:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-chmp-raccomanda-dupilumab-per-bambini-con-da-severa-dai-6-mesi-ai-5-anni/ 2023-01-30T11:11:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-da-fda-approvazione-accelerata-per-pirtobrutinib-mcl/ 2023-01-30T11:44:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-e-astrazeneca-via-libera-in-europa-a-trastuzumab-deruxtecan-come-monoterapia-per-il-trattamento-di-pazienti-adulti-con-cancro-della-mammella-her2-low/ 2023-01-30T12:14:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-da-aifa-ok-a-rimborsabilita-rinvoq-nella-da/ 2023-01-30T14:14:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-oltre-un-mln-di-dollari-per-migliorare-la-catena-del-freddo/ 2023-01-30T14:59:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumore-colon-retto-metastatico-e-italiana-la-prima-terapia-anti-her2-approvata-da-fda/ 2023-01-31T11:30:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-ce-approva-dupilumab-nellesofagite-eosinofila/ 2023-01-31T15:30:55+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-fda-approva-orserdu-serd-orale-per-il-trattamento-del-cancro-della-mammella/ 2023-01-31T17:15:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ma-la-liquidita-ce-che-anno-sara-il-2023/ 2023-01-31T15:08:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/decarbonizzazione-una-sfida-che-il-pharma-raccoglie/ 2023-01-31T16:01:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanitalk-12023-il-pnrr-e-il-dm77-cambieranno-il-volto-del-ssn-ma-attenzione-a-non-fermarsi-alle-apparenze/ 2023-01-31T16:24:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-fatturato-boom-nel-2022-ma-allarme-per-comirnaty-e-paxlovid/ 2023-02-01T11:41:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-crescono-fatturato-ed-eps/ 2023-02-01T13:34:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mpp-la-strategia-20232025-per-aumentare-laccesso-ai-farmaci/ 2023-02-01T15:16:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-commissione-europea-approva-estensione-aic-di-emicizumab/ 2023-02-01T15:33:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/distribuzione-farmaceutica-adf-bene-che-anche-le-regioni-partecipino-al-tavolo-del-ministero-della-salute/ 2023-02-01T16:34:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ibsa-farmaceutici-tre-cambi-ai-vertici/ 2023-02-01T17:21:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-italia-inventing-for-life-health-summit-riflettori-sulla-sanita-di-domani/ 2023-02-01T18:37:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-italia-nel-2022-il-fatturato-cresce-del-7/ 2023-02-02T10:14:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-per-il-progetto-pink-positive-podcast-su-nutrizione-e-musicoterapia-e-servizi-per-le-pazienti-che-affrontano-il-cancro/ 2023-02-02T10:39:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-servier-un-2022-molto-positivo/ 2023-02-02T17:28:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ue-in-vigore-nuova-piattaforma-per-le-sperimentazioni-cliniche/ 2023-02-02T14:01:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-q4-positivo-ottimismo-per-il-2023/ 2023-02-03T11:36:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amgen-arriva-amjevita-primo-biosimilare-negli-usa-di-humira-abbvie/ 2023-02-03T13:40:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-teresa-graham-nuova-chief-executive-roche-pharmaceuticals/ 2023-02-03T14:10:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/test-di-sterilita-farmaceutica-un-mercato-in-rapida-crescita/ 2023-02-03T15:00:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-dupixent-leader-anche-nel-q4-2022/ 2023-02-06T14:11:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiude-medicago-addio-al-vaccino-vegetale-contro-il-covid19/ 2023-02-06T14:43:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-lunga-marcia-dei-vaccini-contro-lhiv/ 2023-02-06T15:42:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dispositivi-medici-ema-monitorera-le-carenze-durante-le-emergenze-sanitarie/ 2023-02-06T17:20:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-awards-le-imprese-del-farmaco-di-fronte-alla-sfida-della-reputazione/ 2023-02-21T15:00:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ok-ce-a-dapagliflozin-nel-trattamento-dello-scompenso-cardiaco-cronico-sintomatico/ 2023-02-07T11:19:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-aumentano-le-vendite/ 2023-02-07T14:10:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-fda-estende-indicazione-trodelvy-nel-cancro-della-mammella/ 2023-02-07T14:42:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/catalent-rumors-sulla-vendita/ 2023-02-07T15:09:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-da-studio-globale-di-fase-iii-risultati-positivi-per-crovalimab-nella-epn/ 2023-02-07T15:27:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/catalent-rinforza-la-partnership-con-moderna/ 2023-02-08T11:23:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-ceo-gonzalez-pronti-a-nuovi-mega-merger/ 2023-02-08T11:50:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-uno-stabilimento-in-giappone-per-produrre-vaccino-covid19/ 2023-02-08T14:09:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sclerosi-multipla-rivedere-i-criteri-di-rimborsabilita-delle-terapie-lappello-dal-regional-summit-di-sics/ 2023-02-08T15:23:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-bayer-bill-anderson-e-il-nuovo-ceo/ 2023-02-09T16:53:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terremoto-in-turchia-e-siria-da-novartis-e-bayer-i-primi-aiuti/ 2023-02-09T13:40:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-digitali-il-nice-dice-si-alle-app-di-cbt-per-ragazzi-con-ansia/ 2023-02-09T14:04:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ematologia-gli-agenti-cd19-cart-daranno-impulso-al-mercato/ 2023-02-09T14:35:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-nuovi-dati-positivi-per-faricimab-nellocclusione-venosa-retinica/ 2023-02-10T17:24:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biontech-apre-nuovo-impianto-di-produzione-in-germania/ 2023-02-10T11:07:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-2022-in-flessione-il-rilancio-punta-su-austedo-e-ajovy/ 2023-02-10T11:49:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-raggiunto-lobiettivo-di-40-mld-di-dollari-di-fatturato/ 2023-02-10T14:44:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-italia-regina-vasiliou-nominata-general-manager/ 2023-02-10T17:20:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-avvia-revisione-sui-farmaci-per-raffreddore-e-influenza-a-base-di-pseudoefedrina/ 2023-02-12T09:57:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/loli-pharma-obiettivo-carbon-neutral-nel-2023/ 2023-03-22T10:31:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assosalute-2022-anno-della-riscossa-per-i-farmaci-senza-obbligo-di-prescrizione/ 2023-02-13T14:47:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-aumentano-i-ricavi-netti/ 2023-02-13T17:25:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-dopo-quella-accelerata-piena-approvazione-fda-per-jemperli-dostarlimab/ 2023-02-13T14:32:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tecnologia-digitale-sempre-piu-presente-negli-studi-di-neurologia/ 2023-02-13T15:31:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-awards-la-sfida-dellinnovazione-va-oltre-il-prodotto-e-riguarda-il-sistema/ 2023-02-21T15:03:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-lascia-reed-responsabile-della-rd/ 2023-02-14T10:55:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-e-biontech-al-via-sperimentazione-sulluomo-del-vaccino-contro-lherpes-zoster-basato-su-mrna-messaggero/ 2023-02-14T11:30:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/genentech-roche-nuovo-impianto-di-produzione-in-california/ 2023-02-14T11:44:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/iss-nuove-nomine-nel-cda/ 2023-02-14T16:46:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-awards-aziende-sempre-piu-green-e-attente-al-sociale/ 2023-02-21T15:02:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-stop-alla-collaborazione-con-vir-biotechnology-su-covid19/ 2023-02-15T11:20:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/clover-introduce-il-vaccino-a-subunita-anti-covid-19-in-cina/ 2023-02-15T11:39:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/principi-attivi-a-elevata-potenza-boom-nel-2026/ 2023-02-15T14:06:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kyowa-kirin-marilena-ritrovato-e-la-nuova-legal-compliance-director-per-il-sud-europa/ 2023-02-16T10:12:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bausch-lomb-brent-saunders-ex-allergan-e-il-nuovo-ceo/ 2023-02-16T10:39:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-la-cura-dimagrante-del-ceo-viehbacher/ 2023-02-16T15:00:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-su-nejm-i-risultati-positivi-per-il-candidato-vaccino-contro-rsv/ 2023-02-16T15:03:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-award-al-centro-del-marketing-non-ce-piu-il-prodotto-ma-le-persone/ 2023-02-21T15:07:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lonza-espande-limpianto-di-bioconiugazione/ 2023-02-18T16:32:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/progetto-impactive-meccanochimica-nella-produzione-di-farmaci/ 2023-02-18T17:17:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-crescono-gli-accordi-di-condivisione-del-rischio/ 2023-02-19T16:19:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-pubblica-rapporto-human-medicines-highlights-2022/ 2023-02-20T16:41:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-autorizza-primo-farmaco-per-patologia-oculare-irreversibile/ 2023-02-20T11:57:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-malattie-rare-via-libera-a-lamzede-anche-da-fda/ 2023-02-20T14:32:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/confindustria-dm-negli-ospedali-italiani-tac-mammografi-e-risonanze-magnetiche-sempre-piu-vecchi/ 2023-02-20T16:18:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-medico-della-generazione-z-e-tik-tok/ 2023-02-21T13:24:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-restituisce-a-biotech-usa-i-diritti-su-candidato-rnai-per-cura-nash-in-fase-precoce/ 2023-02-21T13:55:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/confindustria-dm-stop-al-payback/ 2023-02-21T14:19:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-awards-pazienti-sempre-piu-protagonisti-degli-studi-clinici/ 2023-02-21T15:07:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/csl-behring-gmbh-ce-approva-prima-terapia-genica-per-lemofilia-b/ 2023-02-22T15:52:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-novartis-gilbert-ghostine-nominato-presidente-del-cda/ 2023-02-22T16:02:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-nice-raccomanda-tre-farmaci-per-la-fase-discendente-del-covid/ 2023-02-22T15:57:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-nuova-approvazione-fda-per-austedo/ 2023-02-22T16:03:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/grunenthal-italia-riceve-la-certificazione-per-la-parita-di-genere/ 2023-02-23T10:27:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-conclude-un-altro-accordo-per-lediting-genetico/ 2023-02-23T10:57:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/apple-monitoreremo-la-glicemia-con-un-apple-watch/ 2023-02-23T11:39:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/adv-comunita-lgbtqia-piu-attenzione-alla-nostra-identita/ 2023-02-23T14:05:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-e-msd-da-fda-designazione-di-terapia-innovativa-per-vaccino-melanoma/ 2023-02-23T15:51:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/epilessia-la-lotta-allo-stigma-tra-le-priorita-della-futura-legge-le-riflessioni-a-camerae-sanitatis/ 2023-02-23T16:40:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-flessione-nel-q4-2022/ 2023-02-24T10:41:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ok-ce-a-combo-imfinzi-imjudo-per-i-tumori-in-fase-avanzata-di-fegato-e-polmone/ 2023-02-24T11:10:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nice-raccomanda-opdivo-bms-come-neoadiuvante-contro-il-tumore-del-polmone/ 2023-02-24T11:41:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-award-i-vantaggi-di-uninformazione-medico-scientifica-sempre-piu-digitale/ 2023-02-24T14:23:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-e-sobi-fda-approva-altuviiio-per-lemofilia-a/ 2023-02-24T13:45:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-msd-e-ridgeback-forniscono-un-aggiornamento-sulla-domanda-di-aic-di-molnupiravir-in-ue/ 2023-02-24T17:10:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/incyte-da-chmp-parere-positivo-per-ruxolitinib-crema-per-la-vitiligine/ 2023-02-27T14:10:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-restituisce-a-blueprint-i-diritti-su-gavreto-trattamento-contro-il-cancro-del-polmone/ 2023-02-27T14:09:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/maturita-social-bms-bi-e-roche-sul-podio/ 2023-02-27T15:05:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/servier-ok-chmp-per-ivosidenib-nella-lma-e-nel-cca-con-mutazione-idh1/ 2023-02-27T17:50:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-torna-la-shingle-awareness-week/ 2023-02-27T16:22:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-parere-positivo-chmp-per-rinvoq-nel-trattamento-degli-adulti-con-malattia-di-crohn-da-moderata-a-severa/ 2023-02-28T10:28:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-al-via-la-campagna-il-valore-del-tempo-nella-giornata-delle-malattie-rare/ 2023-02-28T15:59:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-global-rare-diseases-ok-chmp-a-pegunigalsidasi-alfa-per-la-malattia-di-fabry/ 2023-02-28T11:48:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viatris-da-aprile-il-nuovo-ceo-sara-scott-smith/ 2023-02-28T13:36:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-seagen-nel-mirino/ 2023-02-28T14:14:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/viatris-intergratore-estromineral-serena-per-le-donne-in-menopausa/ 2023-02-28T17:05:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-gruppo-biofarma-nomina-gianfranco-nazzi-nuovo-amministratore-delegato/ 2023-03-01T10:45:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-la-reputazione-si-traduce-in-prescrizione/ 2023-03-01T11:38:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jazz-pharmaceuticals-a-stefania-cercone-il-ruolo-di-medical-director-italia/ 2023-03-01T11:51:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ue-revisione-della-legislazione-farmaceutica-i-dubbi-di-efpia/ 2023-03-01T16:35:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/un-filo-per-la-vita-insufficienza-intestinale-cronica-benigna-e-sindrome-dellintestino-corto-come-migliorare-il-percorso-socio-assistenziale/ 2023-03-01T16:05:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-astrazeneca-novartis-e-universita-di-manchester-per-produzione-di-oligonucleotidi/ 2023-03-02T10:22:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/al-via-settima-edizione-del-bando-fondazione-roche-per-la-ricerca-indipendente/ 2023-03-02T10:41:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-primo-si-fda-a-vaccino-rsv-approvazione-attesa-a-maggio/ 2023-03-02T13:39:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/carenza-professionisti-il-vero-problema-e-la-scarsa-attrattivita-del-ssn/ 2023-03-02T15:42:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rimborsabilita-di-bimekizumab-e-via-alla-campagna-metti-la-psoriasi-fuori-gioco/ 2023-03-02T15:28:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-menarini-cresce-il-fatturato-2022/ 2023-03-02T17:16:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/blueprint-malattie-rare-arriva-in-italia-avapritinib/ 2023-03-02T15:04:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/formazione-ecm-le-associazioni-dei-provider-incontrano-le-istituzioni-aggiornamento-continuo-centrale-per-il-governo/ 2023-03-02T16:31:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-paxolivid-ce-autorizza-immissione-incondizionata-in-commercio/ 2023-03-03T09:15:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/giornata-internazionale-contro-lhpv-roche-diagnostics-vaccino-e-screening-prevengono-il-tumore/ 2023-03-03T11:01:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-a-boston-un-centro-di-ricerca-e-sviluppo/ 2023-03-03T11:49:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaceutica-cresce-il-gap-fra-investimenti-in-usa-e-ue/ 2023-03-03T13:53:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-linee-guida-per-unindustria-farmaceutica-agile/ 2023-03-03T14:26:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-award-la-sfida-e-i-benefici-delle-real-world-evidence/ 2023-03-09T14:04:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-autorizza-test-di-farmaco-per-editing-genetico-in-vivo/ 2023-03-06T13:18:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/merck-kgaa-2022-positivo-per-le-vendite/ 2023-03-06T13:45:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-proteici-dal-mit-un-nuovo-processo-di-produzione/ 2023-03-06T14:33:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-nelloxfordshire-il-nuovo-centro-di-innovazione-e-tecnologia/ 2023-03-07T11:29:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-awards-la-rivoluzione-digitale-e-gia-cominciata-ma-la-sfida-e-ancora-lunga/ 2023-03-09T14:03:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-avanzate-vertex-supporta-progetto-per-facilitarne-laccesso/ 2023-03-07T17:20:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-partnership-con-voyager-per-terapie-geniche/ 2023-03-07T14:05:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-buoni-risultati-per-mk-0616-nel-trattamento-dellipercolesterolemia/ 2023-03-07T14:32:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dalle-aziende-francesi-in-italia-un-manifesto-per-creare-ssn-virtuoso/ 2023-03-08T09:47:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-ok-ce-a-luspatercept-per-anemia-associata-a-beta-talassemia-non-trasfusione-dipendente/ 2023-03-08T10:52:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/8-marzo-amref-e-msd-italia-insieme-per-combattere-le-mutilazioni-genitali-femminili/ 2023-03-08T11:30:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-e-affibody-accordo-per-sviluppare-e-commercializzare-trattamenti-innovativi-per-le-malattie-respiratorie/ 2023-03-08T11:45:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gemmato-la-governance-farmaceutica-allattenzione-del-governo/ 2023-03-08T13:45:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rna-non-solo-vaccini/ 2023-03-08T16:38:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amarin-analsi-post-hoc-studio-reduce-it-supporta-icosapent-etile-dopo-sca/ 2023-03-08T17:01:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-caroline-dorsa-nuovo-presidente-del-cda/ 2023-03-09T16:16:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sun-pharma-acquisisce-concert-pharmaceuticals/ 2023-03-09T10:30:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/jj-scommette-su-startup-per-farmaci-neurologici-di-nuova-concezione/ 2023-03-09T11:41:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipercolesterolemia-l80-dei-pazienti-in-cura-non-raggiunge-valori-target-aifa-approva-nuovo-trattamento-first-in-class/ 2023-03-09T14:59:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/giornata-mondiale-del-rene-campagnoli-gsk-belinumab-nella-nefrite-lupica-primo-passo-del-nostro-percorso-in-nefrologia/ 2023-03-09T15:42:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattia-venosa-cronica-spia-di-problemi-al-cuore/ 2023-03-09T16:28:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattie-infiammatorie-croniche-intestinali-nuovi-dati-positivi-a-lungo-termine-su-ustekinumab/ 2023-03-09T16:47:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/in-gb-semaglutide-approvato-dal-nice-per-la-perdita-di-peso/ 2023-03-10T10:37:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eisai-e-biogen-entro-il-6-luglio-approvazione-piena-fda-per-leqembi/ 2023-03-10T10:41:57+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-impianto-di-produzione-in-slovenia-per-i-biosimilari/ 2023-03-10T11:04:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oragenics-e-inspirevax-accordo-per-vaccino-intranasale-anti-covid19/ 2023-03-10T11:29:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/long-covid-un-vecchio-anti-diabetico-riduce-del-42-i-sintomi/ 2023-03-10T13:45:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-aifa-sospende-lantivirale-molnupiravir-no-problemi-di-sicurezza-ma-mancanza-benefici/ 2023-03-10T17:15:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipertensione-arteriosa-polmonare-promettente-terapia-in-1-sola-compressa/ 2023-03-13T08:45:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-approva-spray-nasale-contro-lemicrania-a-luglio-nelle-farmacie-usa/ 2023-03-13T08:44:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sindrome-di-tourette-un-dispositivo-da-polso-riduce-i-sintomi/ 2023-03-13T10:15:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/report-aifa-su-valutazioni-economiche-farmaci-106-dossier-analizzati-nel-2022/ 2023-03-13T11:43:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/partnership-leo-pharma-icon-per-promuovere-trial-nella-dermatologia/ 2023-03-13T09:28:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ipercolesterolemia-su-inibitori-pcsk9-nuovi-dati-di-efficacia-e-aderenza/ 2023-03-13T15:10:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-arriva-la-grande-operazione-acquisita-seagen-per-43-mld-di-dollari/ 2023-03-14T09:48:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-crollo-di-svb-nellannus-horribilis-delle-startup-biotech/ 2023-03-14T10:26:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-acquisisce-provention-bio-e-raddoppia-sul-mercato-del-diabete/ 2023-03-14T11:10:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ibsa-nuova-formulazione-di-vitamina-d-in-film-orodispersibile-e-in-capsule-molli/ 2023-03-14T11:45:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuovi-dati-positivi-su-candidato-vaccino-meningococcico-gsk-5-in-1-copre-sierogruppi-abcwy/ 2023-03-14T12:29:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/endocrinologi-ame-la-carenza-di-semaglutide-non-diventi-motivo-per-stigmatizzare-il-paziente-obeso/ 2023-03-14T13:26:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/menarini-stemline-ok-aifa-a-tagraxofusp/ 2023-03-14T14:28:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-nuovo-round-di-buyback-da-10-mld-di-franchi-svizzeri/ 2023-03-14T14:56:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-entra-nel-mercato-dermatologico-indiano-con-copellor/ 2023-03-15T10:30:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-vaccines-institute-for-globalhealth-di-siena-compie-15-anni-19-progetti-in-corso/ 2023-03-15T10:42:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-fermata-mm-per-celebrare-il-mese-di-sensibilizzazione-sul-mieloma-multiplo/ 2023-03-15T10:58:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nasce-lera-dei-farmaci-a-rna/ 2023-03-15T14:12:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/linformazione-a-misura-di-bimbo-nasce-quotidiano-pediatria/ 2023-03-15T10:18:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/endocrinologi-carenza-farmaco-anti-diabete-non-diventi-stigma-per-pazienti-obesi/ 2023-03-15T17:30:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/servizio-sanitario-britannico-apre-centro-per-sviluppo-e-produzione-terapie-cellulari-e-geniche/ 2023-03-16T10:40:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dispositivi-medici-nasce-losservatorio-nazionale-dei-prezzi/ 2023-03-16T10:54:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lg-chem-accordo-con-unicef-per-fornitura-vaccini-antipolio-e-pentavalente/ 2023-03-16T11:24:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-seagen-stress-test-per-lantitrust-usa/ 2023-03-16T15:00:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-il-nice-approva-finanziamento-nhs-di-zolgensma/ 2023-03-17T10:38:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-nello-spazio-per-studiare-la-bioproduzione/ 2023-03-19T17:15:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fibrosi-un-startup-attira-lattenzione-di-quattro-big-pharma/ 2023-03-19T16:32:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/carenza-amoxicillina-cda-ema-piu-flessibilita-per-consentire-la-distribuzione-di-medicinali-che-potrebbero-non-essere-autorizzati/ 2023-03-19T16:49:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapia-genica-sma-dimostrati-i-benefici-a-lungo-termine/ 2023-03-20T12:44:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-e-pfizer-nuove-importanti-evidenze-per-xtandi/ 2023-03-20T12:54:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/marketing-digitale-momento-di-stallo-ma-non-per-tik-tok/ 2023-03-20T13:23:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sma-nuovi-dati-su-risdiplam-a-4-anni-confermano-efficacia-sicurezza-a-lungo-termine/ 2023-03-20T12:54:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/samsung-bio-nuovo-impianto-cdmo-da-15-miliardi-di-dollari/ 2023-03-20T14:00:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/servier-vorasidenib-raggiunge-endpoint-primario-in-studio-indigo-su-glioma-a-basso-grado-idh-mutato/ 2023-03-20T14:41:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/efpia-alla-commissione-ue-cruciale-valutazione-preventiva-su-nuova-legislazione-farmaceutica/ 2023-03-20T16:43:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biontech-fa-shopping-in-usa-acquisita-licenza-per-inibitore-del-ctla4/ 2023-03-21T11:23:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mhra-britannica-sperimenta-robot-per-la-produzione-di-cellule-staminali/ 2023-03-21T11:48:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/un-ssn-sostenibile-passa-anche-attraverso-le-vaccinazioni-in-eta-adulta/ 2023-03-21T13:13:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-30-anni-in-gastroenterologia-a-milano-levento-imagine-the-future/ 2023-03-21T14:39:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/trapianto-rene-un-percorso-per-garantire-ai-pazienti-altamente-sensibilizzati-equita-di-cure/ 2023-03-21T15:17:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kite-gilead-yescarta-prolunga-la-sopravvivenza-nel-linfoma-a-grandi-cellule-b/ 2023-03-22T10:14:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-italia-e-cef-per-una-farmacia-carbon-neutral/ 2023-03-22T10:47:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-della-nash-e-gara-a-due/ 2023-03-22T11:17:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-la-via-usa-per-incentivare-la-produzione/ 2023-03-22T13:44:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-19-nei-pazienti-fragili-dati-real-life-promuovono-anticorpi-monoclonali/ 2023-03-22T13:45:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/baxter-celltrion-e-thermo-fisher-interessate-a-biopharma-solutions/ 2023-03-22T14:25:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/incyte-ok-fda-a-zynyz-nel-carcinoma-a-cellule-di-merkel/ 2023-03-23T11:02:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-e-eli-lilly-partnership-per-un-test-del-sangue-per-identificare-lalzheimer/ 2023-03-23T11:33:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boggetti-confindustria-dm-no-a-soluzioni-lesive-della-concorrenza-e-degli-investimenti/ 2023-03-23T17:44:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/scelte-value-based-per-un-ssn-piu-efficace-e-sostenibile/ 2023-03-23T15:29:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-nuova-grande-struttura-in-giappone-per-la-produzione-di-plasma/ 2023-03-24T10:01:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-nice-approva-terapia-genica-di-ptc-therapeutics-per-una-malattia-ultra-rara/ 2023-03-24T10:40:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-nuovo-accordo-per-terapie-genetiche/ 2023-03-24T10:39:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sperimentazioni-cliniche-mhra-punta-a-semplificazione-e-tempi-rapidi/ 2023-03-24T12:52:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/farmaci-il-lento-tramonto-del-foglietto-illustrativo/ 2023-03-24T13:44:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuovo-rinvio-per-la-revisione-della-legislazione-farmaceutica-europea/ 2023-03-24T14:17:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sclerosi-multipla-anche-la-genitorialita-e-un-diritto-dei-pazienti-nuovi-spunti-dal-regional-summit-di-sics-dedicato-allemilia-romagna/ 2023-03-24T14:21:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/life-science-excellence-awards-2022-schillaci-servizio-sanitario-nazionale-deve-tornare-punto-di-riferimento-dei-cittadini/ 2023-03-25T09:18:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-32-milioni-di-euro-di-investimenti-per-ampliare-il-sito-di-torre-annunziata/ 2023-03-27T11:30:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-bilancio-di-meta-cammino-per-il-nuovo-corso-delle-attivita-regolatorie/ 2023-03-27T13:01:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-dopo-10-anni-ok-a-nuovo-antimicotico/ 2023-03-27T13:23:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/startup-biotech-i-fondi-venture-capital-chiudono-i-rubinetti/ 2023-03-27T16:12:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-fao-unep-e-woah-call-to-action-per-potenziare-lapproccio-one-health/ 2023-03-27T15:36:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/carcinoma-mammario-precoce-risultati-positivi-su-ribociclib/ 2023-03-28T07:46:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-lancia-in-india-soliqua-diabete/ 2023-03-28T09:19:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-merck-kgaa-stop-alla-partnership-per-bavencio/ 2023-03-28T09:52:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biontech-q4-2022-in-flessione-virata-strategica-sulloncologia/ 2023-03-28T10:52:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sla-una-proteina-sotto-la-lente-di-ingrandimento-della-fda/ 2023-03-28T12:50:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/carcinoma-endometriale-dostarlimab-piu-chemioterapia-migliora-la-sopravvivenza/ 2023-03-28T14:22:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cambio-al-vertice-roche-italia-tsamousis-nuovo-gm-de-cicco-resta-presidente-cda/ 2023-03-29T08:19:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-scommette-sulle-terapie-con-cellule-treg/ 2023-03-29T09:17:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-focus-sui-radiofarmaci-contro-il-cancro/ 2023-03-29T14:20:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-network-di-dati-real-life-sui-farmaci-darwin-eu-completa-i-primi-studi-e-lancia-un-appello-per-trovare-nuovi-partner/ 2023-03-29T10:21:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-1-mld-di-dollari-per-sito-di-produzione-in-irlanda/ 2023-03-29T14:02:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-sceglie-la-tecnologia-di-editing-genico-crispr-therapeutics-per-nuovi-farmaci-contro-il-diabete/ 2023-03-29T14:19:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanitalk-3-la-sanita-privata-non-e-un-nemico-il-problema-e-il-depotenziamento-della-sanita-pubblica/ 2023-03-30T08:44:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hiv-viatris-cipla-e-aurobindo-produrranno-generico-di-apretude-gsk-per-paesi-a-medio-e-basso-reddito/ 2023-03-30T10:47:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/uk-fondi-per-ricerca-e-produzione-a-quattro-pharma/ 2023-03-30T12:22:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-ce-approva-sotyktu-psoriasi-a-placche/ 2023-03-30T15:17:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-arriva-in-italia-cibinqo-per-la-dermatite-atopica/ 2023-03-30T13:06:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sclerosi-multipla-la-nuova-frontiera-e-la-personalizzazione-delle-cure-le-riflessioni-alla-puntata-del-regional-summit-dedicata-alla-sardegna/ 2023-03-31T06:26:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-90-milioni-di-dollari-per-i-diritti-di-un-antimicotico/ 2023-03-31T09:40:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-eisai-previsioni-rosee-per-leqembi/ 2023-03-31T10:04:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-un-impianto-di-produzione-mrna-anche-in-kenya/ 2023-03-31T12:36:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/test-di-microbiologia-rapida-mercato-in-forte-crescita/ 2023-03-31T13:00:50+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-358-procedure-di-mutuo-riconoscimento-e-decentrate-ricevute-nel-2022-finalizzate-295/ 2023-03-31T13:41:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lema-approva-un-nuovo-vaccino-booster-contro-covid-19/ 2023-03-31T13:43:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/investimenti-esteri-payback-proprieta-intellettuale-al-centro-del-tavolo-mimit-sul-pharma/ 2023-03-31T13:50:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/hta-dispositivi-medici-da-agenas-le-coordinate-per-governare-le-tecnologie-arriva-il-programma-nazionale-20232025/ 2023-04-03T12:39:27+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-cina-approva-vaccino-a-mrna-per-uso-in-emergenza/ 2023-04-03T12:41:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sartorius-punta-al-mercato-della-terapia-genica-con-un-accordo-da-26-mld-di-dollari/ 2023-04-03T12:55:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/diabete-favorire-laccesso-del-paziente-allinnovazione/ 2023-04-03T13:16:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/aifa-trend-in-riduzione-delluso-di-antibiotici-in-italia-ma-consumi-ancora-alti/ 2023-04-03T13:37:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/payback-dispositivi-medici-confidustria-dm-commissione-ue-apra-procedura-dinfrazione-contro-litalia-sulla-questione/ 2023-04-03T14:23:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/mepolizumab-terapia-di-precisione-per-le-malattie-eosinofile/ 2023-04-04T10:29:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattia-renale-cronica-societa-scientifiche-pazienti-e-politica-insieme-per-un-nuovo-documento-di-indirizzo/ 2023-04-05T09:39:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-5-decisioni-da-monitorare-nel-secondo-trimestre-2023/ 2023-04-04T10:27:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biontech-continua-a-espandere-la-pipeline-oncologica/ 2023-04-04T12:44:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/obesita-un-mercato-da-37-mld-di-dollari-nel-2031/ 2023-04-04T14:45:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-e-crispr-presentano-domanda-alla-fda-per-exa-cel-farmaco-per-lediting-genetico/ 2023-04-05T09:45:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid19-gli-anticorpi-riducono-il-rischio-di-ospedalizzazione/ 2023-04-05T12:23:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nuove-funzionalita-per-il-programma-priority-medicines-prime-di-ema/ 2023-04-05T12:34:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/in-europa-autorizzati-89-nuovi-medicinali-nel-2022/ 2023-04-05T12:34:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/prevenzione-nuove-terapie-e-uso-corretto-dei-farmaci-le-3-direttrici-da-seguire-per-affrontare-la-pandemia-silente-dellantimicrobico-resistenza/ 2023-04-05T12:53:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/quasi-18-milioni-di-italiani-in-cura-con-anticoagulanti-per-un-totale-di-10-mln-di-ricette/ 2023-04-06T12:08:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/psoriasi-a-placche-via-libera-in-ue-a-inibitore-orale-della-tyk2-first-in-class/ 2023-04-06T12:14:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/shionogi-fast-track-fda-per-ensitrelvir-antivirale-per-covid-19/ 2023-04-06T12:17:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-nuove-raccomandazioni-per-luso-dei-vaccini-covid/ 2023-04-06T12:43:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/efpia-trovare-strade-per-affrontare-accesso-e-disponibilita-farmaci-al-di-fuori-della-nuova-legislazione-ue/ 2023-04-07T12:31:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-italia-fedora-gasperini-e-la-nuova-director-head-of-human-resources/ 2023-04-07T08:43:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-su-nejm-dati-promettenti-per-il-vaccino-rsv/ 2023-04-07T09:53:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-nice-raccomanda-olaparib-per-il-trattamento-dei-tumori-della-mammella-e-della-prostata/ 2023-04-07T10:25:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-fda-traccia-un-percorso-per-lo-sviluppo-di-farmaci-incentrati-sul-paziente/ 2023-04-07T13:24:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/stop-pillola-abortiva-in-texas-400-ceo-condannano-la-sentenza/ 2023-04-11T07:39:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/una-nuova-era-di-vaccini-mrna-per-cancro-e-altre-malattie-moderna-ne-e-convinta-e-si-espone-ce-la-faremo-entro-il-2030/ 2023-04-11T09:37:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/intelligenza-artificiale-in-medicina-in-arrivo-un-nuovo-giornale-del-new-england/ 2023-04-11T16:01:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/supply-chain-delle-terapie-cellulari-e-geniche-mercato-in-forte-espansione/ 2023-04-11T13:17:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ecco-come-funzionera-la-nuova-aifa-pronto-il-decreto-attuativo-sulle-modalita-di-nomina-del-presidente-cda-direttore-amministrativo-e-tecnico-scientifico/ 2023-04-12T07:48:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-vaccino-antitumorale-con-keytruda-msd-riceve-designazione-prime-da-ema/ 2023-04-12T09:35:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-veneno-technologies-accordo-giapponese-per-ricerca-su-nuovi-farmaci/ 2023-04-12T10:03:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/clovis-oncology-cede-le-attivita-rimanenti-per-70-milioni-di-dollari/ 2023-04-12T10:18:02+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-al-via-i-nuovo-bandi-300mila-euro-per-la-ricerca-clinica-e-240-mila-per-la-sclerosi-multipla/ 2023-04-12T12:18:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-e-aspect-accordo-da-26-miliardi-di-dollari-per-terapia-cellulare-contro-il-diabete/ 2023-04-13T09:18:43+00:00 monthly 0.2 https://www.dailyhealthindustry.it/almirall-al-via-primo-studio-europeo-olistico-sulla-dermatologia/ 2023-04-13T10:09:15+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gruppo-servier-un-reality-calcistico-per-parlare-di-aderenza-terapeutica-nelle-malattie-cardiometaboliche/ 2023-04-13T12:45:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-lancia-lecosistema-navify/ 2023-04-13T13:43:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/in-usa-nasce-dxcheck-riuscira-a-battere-drgoogle/ 2023-04-13T14:35:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-ok-aifa-a-rimborsabilita-bulevirtide-per-il-trattamento-dellinfezione-cronica-da-virus-hdv/ 2023-04-13T15:01:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novo-nordisk-balzo-delle-previsioni-di-vendita-e-degli-utili-grazie-a-wegoy-e-ozempic/ 2023-04-14T09:35:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-accordo-con-denali-per-sviluppo-terapie-per-lalzheimer/ 2023-04-14T10:04:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ecdc-oms-in-europa-alte-percentuali-di-resistenza-agli-antibiotici-di-ultima-linea/ 2023-04-14T12:52:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/al-pharma-piacciono-digital-e-podcast/ 2023-04-14T12:59:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/abbvie-commissione-europea-approva-rinvoq-per-il-trattamento-della-malattia-di-crohn-da-moderata-a-severa/ 2023-04-17T08:38:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/msd-acquisisce-prometheus-per-108-miliardi-di-dollari/ 2023-04-17T12:52:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-e-msd-presentati-allaacr-i-risultati-della-combo-vaccino-mrna-keytruda-nel-melanoma/ 2023-04-17T14:03:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malaria-ghana-approva-vaccino-delluniversita-di-oxford/ 2023-04-17T16:28:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-la-pharma-piu-presente-online-nel-mondo/ 2023-04-17T15:28:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-al-via-una-campagna-mondiale-di-awareness-sulla-tecnologia-mrna/ 2023-04-18T08:44:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/verso-la-nuova-aifa-obiettivo-iter-veloci-e-raggio-dazione-piu-ampio/ 2023-04-18T09:19:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cresce-il-mercato-dellautomazione-nellindustria-biofarmaceutica/ 2023-04-18T09:43:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-durvalumab-prima-e-dopo-la-chirurgia-riduce-del-32-il-rischio-di-recidiva-progressione-o-morte-nel-nsclc/ 2023-04-18T10:39:56+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amarin-aaron-berg-ceo-pro-tempore/ 2023-04-18T15:21:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-acquisisce-la-canadese-bellus-health/ 2023-04-19T11:58:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-nuovi-stanziamenti-per-i-siti-produttivi/ 2023-04-19T12:18:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-supera-il-traguardo-dei-100-miliardi-di-dollari-di-fatturato/ 2023-04-19T13:33:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-digitali-in-italia-position-paper-per-farle-decollare/ 2023-04-19T14:11:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nasce-alma-farmacie-network-di-pharma-green-holding/ 2023-04-19T14:37:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/b-braun-nasce-il-country-board-italy/ 2023-04-20T09:04:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/live-rarity-un-hackathon-per-portare-la-rarita-nella-quotidianita-premiati-i-progetti-dellaccademia-made-di-siracusa/ 2023-04-20T09:06:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-con-gli-antitumorali-crescono-le-vendite-del-settore-farmaceutico-nel-q1/ 2023-04-20T10:07:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moodys-per-le-big-pharma-e-di-nuovo-tempo-di-ma/ 2023-04-20T13:23:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dmt-per-sclerosi-multipla-settore-da-30-mld-di-dollari-entro-il-2030/ 2023-04-20T14:07:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/a-tu-per-tu-con-joao-carelli-nuovo-general-manager-per-litalia-di-jazz-pharmaceuticals/ 2023-04-21T09:47:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/oms-a-citta-del-capo-un-hub-vaccini-mrna-per-lafrica/ 2023-04-21T15:13:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lifesciences-venture-capital-europee-raccolgono-nuovi-fondi-per-gli-investimenti/ 2023-04-21T12:47:58+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-fda-approva-polivy-nel-linfoma-diffuso-a-grandi-cellule-b/ 2023-04-21T13:24:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/car-t-per-linfoma-nuovi-dati-mostrano-miglioramento-tempi-produzione-e-consegna-terapia/ 2023-04-24T08:57:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-nice-raccomanda-ibrutinib-e-venetoclax-contro-la-leucemia-linfatica-cronica/ 2023-04-24T14:37:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-e-ibm-accordo-per-impiego-calcolo-quantistico-e-ia-nella-ricerca-sullmrna/ 2023-04-24T10:19:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/settimana-europea-della-vaccinazione-emer-cooke-ema-parlate-con-il-vostro-medico-evitate-web-e-social/ 2023-04-24T10:47:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/studi-a-braccio-singolo-ema-avvia-consultazione-pubblica/ 2023-04-24T10:48:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-studio-testa-testa-a-testa-tra-mounjaro-e-wegovy-novo-nordisk/ 2023-04-24T15:36:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biogen-da-fda-approvazione-accelerata-per-tofersen-nella-sla-associata-a-mutazione-sod1/ 2023-04-26T09:30:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/incyte-ce-approva-ruxolitinib-crema-per-il-trattamento-della-vitiligine-non-segmentale-con-coinvolgimento-del-viso-in-adulti-e-adolescenti/ 2023-04-26T09:56:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ema-convalida-la-domanda-di-aic-per-la-combo-dostarlimab-chemioterapia-nel-carcinoma-endometriale/ 2023-04-26T10:12:22+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tumori-ta-associates-investe-in-diatech-pharmacogenomics/ 2023-04-26T11:13:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/giornata-mondiale-della-malaria-ancora-lontana-ununiforme-distribuzione-dei-vaccini/ 2023-04-26T12:29:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/presentata-la-proposta-di-riforma-della-legislazione-farmaceutica-ue-ecco-tutte-le-novita/ 2023-04-26T15:53:17+00:00 monthly 0.2 https://www.dailyhealthindustry.it/giovanni-caforio-ceo-di-bristol-myers-squibb-in-pensione-a-novembre/ 2023-04-27T15:34:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/parere-positivo-del-chmp-per-candidato-vaccino-gsk-contro-il-virus-respiratorio-sinciziale-negli-anziani-ottiene/ 2023-04-27T07:37:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vabysmo-star-del-q1-di-roche/ 2023-04-27T13:06:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/emicrania-biotech-usa-lancia-studio-fase-iii-di-terapia-digitale/ 2023-04-27T13:30:41+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-ottimi-risultati-per-iptacopan-nella-epn/ 2023-04-27T14:48:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/eli-lilly-nel-q1-cresce-il-core-business/ 2023-04-28T08:46:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-q1-trascinato-dal-solito-dupixent-e-dai-vaccini/ 2023-04-28T09:28:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/atrofia-geografica-accordo-boehringer-ingelheim-e-retinai-medical-per-nuovi-trattamenti/ 2023-04-28T10:22:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ok-nice-a-combo-daratumumab-bortezomib-e-desametasone-nella-recidiva-di-mieloma/ 2023-04-28T12:37:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-incrementa-la-produzione-car-t-con-limpianto-di-novartis/ 2023-04-28T13:39:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-acquisisce-iveric-bio-e-si-rafforza-in-oftalmologia/ 2023-05-02T09:23:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-un-2022-fantastico-nellesg/ 2023-05-02T10:05:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-fda-estende-indicazione-vaccino-prevnar-20-a-bambini-e-neonati/ 2023-05-02T12:28:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/patientview-2022-sul-podio-roche-viiv-e-horizon/ 2023-05-02T13:43:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/malattia-psoriasica-a-bari-la-prima-tappa-della-nuova-campagna-informativa-di-novartis/ 2023-05-02T14:41:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanitalk-4-partnership-pubblico-privato-per-portare-innovazione-nel-ssn-e-colmare-il-gap-tra-regioni/ 2023-05-02T15:34:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/johnson-acquisite-due-terapie-cellulari-sperimentali/ 2023-05-03T09:44:00+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-fda-pubblica-una-bozza-di-linee-guida-per-le-sperimentazioni-cliniche-decentralizzate/ 2023-05-03T10:37:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-q1-migliore-delle-previsioni/ 2023-05-03T12:27:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/ozempic-novo-nordisk-farmaco-boom-dei-prossimi-5-anni/ 2023-05-03T14:15:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-fda-approva-il-vaccino-rsv-negli-over-60-e-la-prima-volta-in-questa-popolazione-di-pazienti/ 2023-05-04T09:00:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sclerosi-multipla-in-campania-il-sogno-nel-cassetto-di-una-governance-estesa-e-multiprofessionale/ 2023-05-04T09:09:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/angelini-pharma-erik-lommerde-e-il-nuovo-international-chief-commercial-operations-officer/ 2023-05-04T09:58:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/boehringer-ingelheim-in-germania-nuovo-sito-di-produzione-di-principi-attivi/ 2023-05-04T10:32:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-ok-aifa-a-rimborsabilita-tabrecta-nel-nsclc-metex14-mutato/ 2023-05-04T11:01:05+00:00 monthly 0.2 https://www.dailyhealthindustry.it/carenza-farmaci-parlamento-europeo-piu-impianti-di-produzione-api-nella-ue/ 2023-05-04T16:32:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bms-ce-approva-breyanzi-terapia-car-t-contro-il-linfoma/ 2023-05-04T15:33:11+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kenvue-spinoff-di-jj-ipo-da-38-miliardi-di-dollari/ 2023-05-05T15:54:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vertex-ok-fda-a-kalydeco-per-terapia-per-la-fibrosi-cistica-nei-neonati/ 2023-05-05T09:47:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-forte-flessione-nel-q1-2023/ 2023-05-05T10:23:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regeneron-ricavi-in-aumento-nel-q1/ 2023-05-05T12:58:23+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-dallo-studio-di-fase-iii-neurottransform-ottimi-risultati-per-eplontersen-nel-trattamento-della-attrvpn/ 2023-05-05T14:17:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-oms-dichiara-la-fine-dello-stato-di-emergenza-globale/ 2023-05-05T14:48:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/presentata-a-cosmofarma-23-fofi-live-la-nuova-piattaforma-informativa-per-i-farmacisti-italiani/ 2023-05-05T15:16:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/chiesi-e-protalix-ok-ce-a-prx-102-nella-malattia-di-fabry/ 2023-05-08T12:19:09+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-nasce-linstitute-of-human-biology/ 2023-05-08T16:48:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/passione-visionarieta-entusiasmo-per-le-biotecnologie-al-via-il-premio-early-bioneers-per-giovani-ricercatori-e-startup/ 2023-05-08T15:43:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-italia-giuseppe-pompilio-nuovo-market-access-director/ 2023-05-08T14:13:40+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-regno-unito-negozia-una-riforma-per-il-pagamento-dei-farmaci-branded/ 2023-05-08T15:02:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/janssen-arriva-in-italia-teclistamab-anticorpo-bispecifico-per-il-mieloma-multiplo/ 2023-05-09T08:40:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pharma-mercato-solido-nonostante-il-contesto-outlook-positivo-per-2023-secondo-bain-co/ 2023-05-09T09:06:42+00:00 monthly 0.2 https://www.dailyhealthindustry.it/baxter-cede-la-unit-biopharma-per-425-miliardi-di-dollari/ 2023-05-09T14:50:07+00:00 monthly 0.2 https://www.dailyhealthindustry.it/catalent-taglia-loutlook-2023/ 2023-05-09T14:53:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-ok-aifa-a-rimborsabilita-anifrolumab-nel-les/ 2023-05-10T09:18:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daewoong-pharmaceutical-un-nuovo-stabilimento-per-produrre-il-rivale-mondiale-del-botox/ 2023-05-10T09:56:49+00:00 monthly 0.2 https://www.dailyhealthindustry.it/simef-marie-georges-besse-confermata-presidente-per-il-triennio-2023-25/ 2023-05-10T10:20:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fondazione-menarini-arriva-house-of-sciences-in-un-click-la-scienza-medica-certificata-dal-bmj/ 2023-05-10T12:24:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-acquisita-xinthera-biotech-californiana/ 2023-05-10T13:19:37+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-accordo-con-evotec-per-sviluppo-e-produzione-di-biosimilari/ 2023-05-11T09:31:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/roche-70-milioni-di-dollari-a-biotech-cinese-per-nuovo-farmaco-her2/ 2023-05-11T09:53:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/volontariato-roche-torna-a-farsi-in-4/ 2023-05-11T10:16:52+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sobi-acquisisce-cti-biopharma-con-unoperazione-da-17-mild-di-dollari/ 2023-05-11T16:35:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biontech-primi-risultati-positivi-per-vaccino-a-mrna-contro-il-tumore-del-pancreas/ 2023-05-11T13:21:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/servier-ok-ce-a-ivosidenib-nella-leucemia-mieloide-acuta-e-colangiocarcinoma-idh1mutati/ 2023-05-11T14:05:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/cda-aifa-approva-la-profilassi-pre-esposizione-hiv/ 2023-05-11T14:45:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/incyte-pablo-cagnoni-nuovo-responsabile-ricerca-e-sviluppo/ 2023-05-12T09:25:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/lundbeck-e-otsuka-ok-fda-a-rexulti-nel-trattamento-dellagitazione-associata-alla-demenza-nella-malattia-di-alzheimer/ 2023-05-12T15:19:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/fda-un-documento-sullintelligenza-artificiale-e-lapprendimento-automatico-nello-sviluppo-di-farmaci/ 2023-05-12T12:37:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/nasce-consulcesi-homnya-il-nuovo-partner-di-marketing-e-comunicazione-omnichannel-e-data-driven-per-il-mondo-healthcare-life-science/ 2023-05-12T14:15:38+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amylyx-buone-performance-per-il-farmaco-contro-la-sla/ 2023-05-12T14:12:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccinazione-anti-meningococco-b-limportanza-della-comunicazione-per-una-scelta-consapevole/ 2023-05-12T14:47:24+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rischio-sottofinanziamento-per-i-trial-clinici-con-bambini-piu-costosi-del-59/ 2023-05-12T07:34:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astellas-ok-fda-a-veozah-farmaco-per-la-menopausa/ 2023-05-15T10:46:45+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-e-astrazeneca-beyfortus-riduce-dell83-i-ricoveri-dei-neonati-per-rsv/ 2023-05-15T12:30:32+00:00 monthly 0.2 https://www.dailyhealthindustry.it/takeda-si-prepara-allimpatto-delle-scadenze-dei-brevetti/ 2023-05-15T13:21:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/beckman-coulter-presenta-lanalizzatore-di-nuova-generazione-access-dxi-9000/ 2023-05-15T14:52:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-sette-nuovi-ingressi-nel-cda-guideranno-lo-spin-off-da-novartis/ 2023-05-16T09:10:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-accordo-con-arcus-biosciences-per-ricerca-sulle-malattie-infiammatorie/ 2023-05-16T09:33:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-un-evento-per-disegnare-i-leader-del-futuro-nelle-life-sciences/ 2023-05-16T10:23:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/adc-i-farmaci-della-corsa-alloro/ 2023-05-16T13:29:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/italia-farmaci-generici-un-anno-tra-stagnazione-e-depressione-bene-i-biosimilari/ 2023-05-16T14:07:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bavarian-nordic-amplia-il-portafoglio-vaccini-con-lacquisizione-di-emergent/ 2023-05-17T08:49:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sandoz-e-just-evotec-biologic-partnership-per-la-produzione-di-biosimilari-guidata-dallai/ 2023-05-17T09:12:13+00:00 monthly 0.2 https://www.dailyhealthindustry.it/q1-2023-scende-la-capitalizzazione-di-mercato-ma-non-per-tutti/ 2023-05-17T10:43:14+00:00 monthly 0.2 https://www.dailyhealthindustry.it/astrazeneca-esce-dalla-phrma/ 2023-05-17T12:43:30+00:00 monthly 0.2 https://www.dailyhealthindustry.it/caso-avastin-lucentis-il-consiglio-di-stato-conferma-la-maxi-multa-antitrust/ 2023-05-17T15:11:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/dallema-10-raccomandazioni-alle-aziende-contro-le-carenze-di-farmaci/ 2023-05-17T15:13:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/intervista-al-ceo-gilead-italia-obiettivo-10-farmaci-trasformativi-entro-il-2030-e-per-fare-questo-litalia-e-un-paese-strategico/ 2023-05-17T13:47:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/kite-pharma-cindy-perettie-e-la-nuova-executive-vp/ 2023-05-18T09:16:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/il-nice-raccomanda-nove-terapie-digitali-per-depressione-e-ansia/ 2023-05-18T09:43:10+00:00 monthly 0.2 https://www.dailyhealthindustry.it/biofarma-group-acquisisce-us-pharma-lab-nasce-la-prima-cdmo-globale-specializzata-nella-produzione-di-nutraceutici/ 2023-05-18T14:43:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/assegnati-i-premi-del-bando-aipo-its-su-asma-grave-e-bpco-rivolto-a-medici-under-45/ 2023-05-18T15:25:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaiolo-delle-scimmie-cdc-il-vaccino-di-bavarian-nordic-efficace-fino-all86/ 2023-05-19T09:47:31+00:00 monthly 0.2 https://www.dailyhealthindustry.it/rinvoq-abbvie-il-nice-lo-raccomanda-per-la-malattia-di-chron/ 2023-05-19T10:12:54+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-salute-mentale-a-45-anni-dalla-legge-basaglia-una-priorita-per-i-pazienti-le-famiglie-e-la-comunita/ 2023-05-19T14:34:16+00:00 monthly 0.2 https://www.dailyhealthindustry.it/teva-la-nuova-roadmap-per-il-2027/ 2023-05-19T15:22:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/la-fda-autorizza-la-prima-terapia-genica-a-uso-topico/ 2023-05-22T12:38:46+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bayer-successo-per-la-nutrient-gap-initiative/ 2023-05-22T12:55:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/pfizer-si-avvicina-lok-per-abrysvo-nel-rsv-neonatale/ 2023-05-22T13:28:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/occhio-secco-ok-fda-a-miebo-di-bausch-lomb/ 2023-05-22T13:55:03+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sclerosi-multipla-si-a-reti-e-pdta-specifici-ma-senza-ghettizzare-i-pazienti-le-riflessioni-dal-regional-summit-di-sics-dedicato-alla-liguria/ 2023-05-22T14:56:34+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novartis-acquisisce-da-avrobio-terapia-genica-contro-malattia-rara/ 2023-05-23T09:35:20+00:00 monthly 0.2 https://www.dailyhealthindustry.it/regno-unito-in-ritardo-sugli-studi-clinici/ 2023-05-23T10:07:18+00:00 monthly 0.2 https://www.dailyhealthindustry.it/tecnologia-mrna-ceddia-moderna-allo-studio-21-vaccini-respiratori/ 2023-05-23T15:13:33+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanofi-una-pipeline-per-le-patologie-respiratorie-guidata-da-dupixent/ 2023-05-23T12:31:44+00:00 monthly 0.2 https://www.dailyhealthindustry.it/great-place-to-work-italia-il-biopharma-e-il-settore-piu-virtuoso/ 2023-05-24T09:01:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/alle-biotech-europee-piace-la-svizzera/ 2023-05-24T09:37:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/moderna-primi-dati-incoraggianti-su-terapia-mrna-per-malattia-rara/ 2023-05-24T10:41:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/vaccino-anti-herpes-zoster-nel-diabete-per-gli-esperti-un-modello-di-prevenzione-nei-fragili/ 2023-05-24T12:06:47+00:00 monthly 0.2 https://www.dailyhealthindustry.it/riforma-della-legislazione-farmaceutica-ue-i-dubbi-delle-pharma/ 2023-05-24T15:20:04+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gsk-italia-per-i-momenti-che-contano-nella-famiglia/ 2023-05-24T13:29:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/100-anni-di-novo-nordisk-unazienda-che-guarda-oltre-il-diabete/ 2023-05-25T09:24:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/herpes-zoster-linfezione-aumenta-il-rischio-di-ictus-per-i-successivi-12-anni/ 2023-05-25T11:36:59+00:00 monthly 0.2 https://www.dailyhealthindustry.it/brevetti-green-nel-pharma-il-q1-2023-registra-un-calo/ 2023-05-25T11:57:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/una-nuova-biotech-sulla-scena-dellrna/ 2023-05-25T12:13:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/daiichi-sankyo-acido-bempedoico-riduce-significativamente-il-rischio-di-mace-e-puo-aiutare-piu-pazienti-a-raggiungere-i-target-di-colesterolo-ldl/ 2023-05-25T12:44:21+00:00 monthly 0.2 https://www.dailyhealthindustry.it/medtronic-acquisisce-la-biotech-coreana-eoflow/ 2023-05-26T09:39:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/anteprima-asco-attesa-per-kisqali-novartis/ 2023-05-26T10:15:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/covid-accordo-tra-commissione-europea-e-biontech-pfizer-per-la-fornitura-di-meno-dosi-di-vaccini/ 2023-05-26T15:30:36+00:00 monthly 0.2 https://www.dailyhealthindustry.it/uk-e-horizon-europe-riammissione-vicina/ 2023-05-26T12:26:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/parte-ithaca-il-think-thank-sui-nuovi-modelli-regolatori-e-di-accesso-dei-farmaci/ 2023-05-26T14:49:28+00:00 monthly 0.2 https://www.dailyhealthindustry.it/advanz-pharma-sceglie-milano-per-la-sede-italiana/ 2023-05-26T13:45:39+00:00 monthly 0.2 https://www.dailyhealthindustry.it/novavax-ok-chmp-per-aic-in-europa-e-per-estensione-durata-conservazione-del-vaccino-nuvaxovid/ 2023-05-26T14:04:25+00:00 monthly 0.2 https://www.dailyhealthindustry.it/poliposi-nasale-linfiammazione-ha-un-ruolo-chiave-si-lavora-a-soluzioni-di-precisione/ 2023-05-29T07:56:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/asco-riflettori-puntati-su-un-adc-di-msd/ 2023-05-29T11:42:51+00:00 monthly 0.2 https://www.dailyhealthindustry.it/sanita-e-metaverso-un-amore-non-ancora-sbocciato/ 2023-05-29T12:42:19+00:00 monthly 0.2 https://www.dailyhealthindustry.it/accordo-alvotech-e-advanz-pharna-cinque-biosimilari-per-leuropa/ 2023-05-29T13:06:26+00:00 monthly 0.2 https://www.dailyhealthindustry.it/neuralink-ok-fda-a-studio-clinico-sulluomo-per-device-impiantabile-nel-cervello/ 2023-05-29T13:36:06+00:00 monthly 0.2 https://www.dailyhealthindustry.it/gilead-parere-positivo-chmp-per-remdesivir-nei-pazienti-covid19-con-grave-compromissione-renale/ 2023-05-29T14:18:35+00:00 monthly 0.2 https://www.dailyhealthindustry.it/bando-sanofi-ecco-i-progetti-vincitori-a-sostegno-della-ricerca-indipendente-nel-tumore-al-polmone/ 2023-05-29T15:29:12+00:00 monthly 0.2 https://www.dailyhealthindustry.it/salute-digitale-finanziamenti-costanti-nel-q1-2023-ma-ancora-lontani-dai-mega-round/ 2023-05-30T09:50:29+00:00 monthly 0.2 https://www.dailyhealthindustry.it/immuno-oncologia-un-mercato-che-nel-2028-varra-150-mld-di-dollari/ 2023-05-30T14:58:53+00:00 monthly 0.2 https://www.dailyhealthindustry.it/obesita-per-il-blockbuster-e-corsa-a-due/ 2023-05-30T13:11:08+00:00 monthly 0.2 https://www.dailyhealthindustry.it/inquinamento-e-salute-consulcesi-lancia-azione-collettiva-aria-pulita/ 2023-05-30T13:32:48+00:00 monthly 0.2 https://www.dailyhealthindustry.it/amylyx-sla-se-chmp-dara-parere-negativo-ad-amx0035-chiederemo-riesame-formale/ 2023-05-30T14:39:01+00:00 monthly 0.2 https://www.dailyhealthindustry.it/terapie-car-t-da-bms-al-congresso-asco-nuovi-dati-su-breyanzi-nella-llc/ 2023-05-31T09:02:37+00:00 monthly 0.2